sheenayam的个人主页 - 老虎社区

sheenayam

sheenayam

暂无个人介绍

IP属地：未知

171关注

23粉丝

0主题

0勋章

2021-08-08

Please like and comment

SEC Moves First DeFi Unregistered Securities Lawsuit<blockquote>SEC提起首起DeFi未注册证券诉讼</blockquote>

2021-09-17

Please like

抱歉，原内容已删除

2021-06-17

Please like and comment. Thanks !

Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal<blockquote>高盛支持的SPAC将以26亿美元的交易让Mirion Tech上市</blockquote>

2021-10-02

Comment and like please. Thanks

3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote>

2021-09-14

Please like and comment. Thanks

抱歉，原内容已删除

2021-09-17

Like

抱歉，原内容已删除

2021-08-26

Please like and comment

抱歉，原内容已删除

2021-08-03

Please like and share

Fed Could Start ‘Tapering’ Soon. Don’t Expect It to Cause Havoc for the Stock Market This Time Around.<blockquote>美联储可能很快就会开始“缩减”。不要指望这次会对股市造成严重破坏。</blockquote>

2021-07-17

Please like and comment

抱歉，原内容已删除

2021-08-08

Please like and comment

抱歉，原内容已删除

2021-07-30

Please like and comment. Thanks

抱歉，原内容已删除

2021-07-21

Please like and comment

抱歉，原内容已删除

2021-07-18

Please like and share

抱歉，原内容已删除

2021-07-17

Please like and comment

Coupa Shares Extend Losses After Post-Analyst Day Selloff<blockquote>分析师日抛售后，Coupa股价扩大跌幅</blockquote>

2021-07-08

Please like and comment

抱歉，原内容已删除

2021-10-02

Comment and like please. Thanks

抱歉，原内容已删除

2021-09-16

Like

Beyond Meat stock dropped nearly 5% in morning trading<blockquote>Beyond Meat股价早盘下跌近5%</blockquote>

2021-09-15

Please like and comment thanks

抱歉，原内容已删除

2021-08-19

Please like and comment

抱歉，原内容已删除

2021-08-04

Please like and comment

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3579743164156658","uuid":"3579743164156658","gmtCreate":1617160927098,"gmtModify":1704447520697,"name":"sheenayam","pinyin":"sheenayam","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":171,"tweetSize":234,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"60.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":630163977,"gmtCreate":1642743044396,"gmtModify":1642743044663,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"加油恒瑞","listText":"加油恒瑞","text":"加油恒瑞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630163977","repostId":"2204086873","repostType":2,"repost":{"id":"2204086873","kind":"highlight","weMediaInfo":{"introduction":"小北读财报，带你选白马。","home_visible":1,"media_name":"小北读财报","id":"1061096740","head_image":"https://static.tigerbbs.com/25c953854500faba5b1551a754dd76c9"},"pubTimestamp":1642496254,"share":"https://www.laohu8.com/m/news/2204086873?lang=zh_CN&edition=full","pubTime":"2022-01-18 16:57","market":"us","language":"zh","title":"那些投资恒瑞医药的人，到底在坚持什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2204086873","media":"小北读财报","summary":"我想，投资恒瑞医药的人应该都是这么认为的，只是可能没有投资在好的价格上。2022年1月13日，随着恒瑞医药在投资互动平台中回复2021年前三季度企业业绩增速放缓原因，恒瑞医药便又迎来了接连几日的下跌，昨日甚至进入到了沪股通成交榜，被净卖出了7252.92万元。（注明：药品红字部分指恒瑞医药已上市的7款创新药，恒瑞医药目前共有10款创新药。","content":"<html><body><p><strong><span>巴菲特曾经说过对于质优股永远不卖，</span></strong>他曾说，如果你给我1000亿美元用以交换<a href=\"https://laohu8.com/S/KO\">可口可乐</a>这种饮料在世界上的领先权，我会把钱还给你，并对你说‘这可不成’。<strong><span>但巴菲特也会说，</span></strong>当人们忘记“二加二等于四”这种最基本的常识时，就该是脱手离场的时候了，<a href=\"https://laohu8.com/S/BRK.A\">伯克希尔</a>的保险子公司也曾通过套利获得了异常巨大的利润。</p><p><strong><span>如果将巴菲特的投资原则提炼一下的话，那就是对于有高的竞争壁垒（或者说特许经营权）的企业不会卖出，但也会买卖市场上的价格与价值出现偏离的股票。</span></strong></p><p>那这时候我就想到了<strong><span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span></strong>，它是属于巴菲特认为的哪一类呢，而显然，在我看来，<strong><span>它一定是属于有高竞争壁垒的前者。</span></strong>我想，投资恒瑞医药的人应该都是这么认为的，只是可能没有投资在好的价格上。</p><p>话不多说，好久没跟踪恒瑞医药了，我们来看看它现在怎么样了。</p><p><strong><span>一、业绩增速放缓仍然刺激着股价短期走势</span></strong></p><p>根据业绩预增披露原则，近期已有不少企业陆陆续续披露了业绩预增报告，但对于恒瑞医药来说，今年的业绩预增报告肯定是没戏了（净利润同比增长50%或下降50%以上）。</p><p><strong><span>2022年1月13日，随着恒瑞医药在投资互动平台中回复2021年前三季度企业业绩增速放缓原因，恒瑞医药便又迎来了接连几日的下跌，</span></strong>昨日甚至进入到了沪股通成交榜，被净卖出了7252.92万元。许久不见，大家还是那么情绪化。</p><div><img img_height=\"397\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/972a9c440ebf4d03b7e03db42565ed92\"/></div><p><strong><span>但显然，这些都不能证明恒瑞医药短期的基本面又发生了大的变动，</span></strong>只能说股价因为资金流入上涨、流出下跌是很正常的事情。</p><p>而且早在2021年，恒瑞医药二季度、三季度业绩便呈现出明显下滑趋势，但它的前十大流通股股东，除了香港中央结算有限公司减持了6.9%之外，其他机构均处于不变甚至增持趋势。</p><p><strong><span>对于恒瑞医药来说，近两年医保谈判以及仿制药集采都因药品单价的大幅下跌而给企业业绩带来不小压力。</span></strong>大产品PD-1于2020年年末加入医保降幅近85%，紧接着在2021年年末又有四款药，其中包括三款创新药，首次纳入了国家医保目录；</p><p><strong><span>除此之外，恒瑞医药一共参与了四次仿制药全国集采，</span></strong>第二次～第五次集采一次都没落下，而且按集采相关规定来看，药品集采对业绩影响一般会在半年后兑现，相关药品收入免不了下降50%。</p><p>所以衡量来看，在2021年恒瑞医药业绩没有明显起色的背景下，考虑2021的集采和谈判，我们似乎认为恒瑞医药2022业绩增长仍有着不小压力。</p><p><strong><span>但如果仅仅是这么考虑，我们可能和那些情绪化的投资者没什么区别，而且有点想当然。</span></strong></p><div><img img_height=\"446\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/cb885e7eaa274609b4bf510bba5f8c45\"/></div><p><em>（注明：药品红字部分指恒瑞医药已上市的7款创新药，恒瑞医药目前共有10款创新药。）</em></p><p><strong><span>二、恒瑞医药2022年业绩增长有何支撑？</span></strong></p><p><strong><span>因为细细追究来看，我们会发现，事情并没有那么悲观，</span></strong>对于恒瑞医药来说，这是一个不断进化的过程，且净利率端还有当前较大的研发压力，恒瑞医药厚积薄发还是有希望的。</p><p><strong><span>1、仿制药集采虽会扩容，但“新药”上市速度在加快</span></strong></p><p>虽然2021年上半年第三次集采的六款仿制药收入下降了57%，但整体来看，恒瑞医药的收入仍然是在增长的，<strong><span>这一方面和我们一直说道的创新药上市密切相关，另一方面是因为“新的”仿制药也在不断上市。</span></strong></p><p>即2021年上半年恒瑞医药共有<strong><span>14款</span></strong>药品获得药（产）品注册批件，其中有近三分之二都是仿制药；相对应的2020年全年，恒瑞医药取得创新药制剂生产批件为<strong><span>6个</span></strong>、仿制药制剂生产批件也仅有<strong><span>5个</span></strong>，<strong><span>创新药和仿制药上市速度都在加快。</span></strong></p><p>同时，由2022年新一年的集采计划目标，按品种数量来看，2022年将实施的两次集采的规模或不会小于前五次。</p><p><strong><span>所以对于恒瑞医药来说，虽然已知集采会不断深化，但恒瑞医药有能力维持着仿制药的收入规模不会出现突然大幅度的下滑。实现业绩平滑是恒瑞医药尽快转型的一个重要方式。</span></strong></p><div><img img_height=\"266\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/b60b164dcbec4dc0a1605db34816886c\"/></div><p><strong><span>2、创新药拐点可能要早于业绩拐点</span></strong></p><p>恒瑞医药目前的创新药销售情况就好比狗熊掰棒子，刚上市一个产品可能不到半年就加入医保谈判降价了，<strong><span>但追究下去的话我们会发现要不是前前后后这些创新药撑着局面，恒瑞医药怎么可能维持着业绩的稳定。</span></strong></p><p>2021年上半年恒瑞医药创新药收入占比为39.15%，收入规模同比增长了43.8%，而这半年创新药新上市产品有1种，2020年新加入医保的为1种，一共有8款创新药；</p><p>2021年下半年，恒瑞医药又新上市了两款创新药，同时在医保内的创新药数量增加了3种（均为谈判），一共有10款创新药，因此从“结构”和规模上看都没有太大问题。</p><p><strong><span>值得一提的是，恒瑞医药新上市的两款创新药，达尔西利、恒格列净分别是首个国产CDK4/6抑制剂、首个国产SGLT-2抑制剂，二者研发投入累计超过了6.37亿元，相当于PD-1 40%的研发规模，不容小觑。</span></strong></p><p>因此，对于恒瑞医药来说，当前研发进程仍在持续加快，作为净利润端的一大影响因素，研发费用率的提升甚至比销售费用率的提升以及毛利率的下降幅度还要大，<strong><span>但没有前者的投入，又怎么能带来销售费用率和毛利率的正向改善，这是一个一比二的关系。</span></strong></p><p><strong><span>三、总结一下</span></strong></p><p><strong><span>总的来看，我们对于恒瑞医药的看法始终没有改变，</span></strong>虽然前期因为企业参与集采以及医保降价，基本面发生了一些变化，但股价下挫最主要的原因还在于前期预期太高了，如果之前股价没有透支未来好几年的情况或许股价下跌幅度会小点。</p><p>展望未来，恒瑞医药见到希望的曙光可能不需要太久，既然2021年不行，那我们就等2022年，如果再出现价格更低的情况反而也是好的，但在抄底之前，我们要做好充分的准备！（比如说现金流折现算一下乐观或悲观情况下，恒瑞医药的价值。）</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>那些投资恒瑞医药的人，到底在坚持什么？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n那些投资恒瑞医药的人，到底在坚持什么？\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1061096740\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/25c953854500faba5b1551a754dd76c9);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">小北读财报 </p>\n<p class=\"h-time\">2022-01-18 16:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><span>巴菲特曾经说过对于质优股永远不卖，</span></strong>他曾说，如果你给我1000亿美元用以交换<a href=\"https://laohu8.com/S/KO\">可口可乐</a>这种饮料在世界上的领先权，我会把钱还给你，并对你说‘这可不成’。<strong><span>但巴菲特也会说，</span></strong>当人们忘记“二加二等于四”这种最基本的常识时，就该是脱手离场的时候了，<a href=\"https://laohu8.com/S/BRK.A\">伯克希尔</a>的保险子公司也曾通过套利获得了异常巨大的利润。</p><p><strong><span>如果将巴菲特的投资原则提炼一下的话，那就是对于有高的竞争壁垒（或者说特许经营权）的企业不会卖出，但也会买卖市场上的价格与价值出现偏离的股票。</span></strong></p><p>那这时候我就想到了<strong><span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span></strong>，它是属于巴菲特认为的哪一类呢，而显然，在我看来，<strong><span>它一定是属于有高竞争壁垒的前者。</span></strong>我想，投资恒瑞医药的人应该都是这么认为的，只是可能没有投资在好的价格上。</p><p>话不多说，好久没跟踪恒瑞医药了，我们来看看它现在怎么样了。</p><p><strong><span>一、业绩增速放缓仍然刺激着股价短期走势</span></strong></p><p>根据业绩预增披露原则，近期已有不少企业陆陆续续披露了业绩预增报告，但对于恒瑞医药来说，今年的业绩预增报告肯定是没戏了（净利润同比增长50%或下降50%以上）。</p><p><strong><span>2022年1月13日，随着恒瑞医药在投资互动平台中回复2021年前三季度企业业绩增速放缓原因，恒瑞医药便又迎来了接连几日的下跌，</span></strong>昨日甚至进入到了沪股通成交榜，被净卖出了7252.92万元。许久不见，大家还是那么情绪化。</p><div><img img_height=\"397\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/972a9c440ebf4d03b7e03db42565ed92\"/></div><p><strong><span>但显然，这些都不能证明恒瑞医药短期的基本面又发生了大的变动，</span></strong>只能说股价因为资金流入上涨、流出下跌是很正常的事情。</p><p>而且早在2021年，恒瑞医药二季度、三季度业绩便呈现出明显下滑趋势，但它的前十大流通股股东，除了香港中央结算有限公司减持了6.9%之外，其他机构均处于不变甚至增持趋势。</p><p><strong><span>对于恒瑞医药来说，近两年医保谈判以及仿制药集采都因药品单价的大幅下跌而给企业业绩带来不小压力。</span></strong>大产品PD-1于2020年年末加入医保降幅近85%，紧接着在2021年年末又有四款药，其中包括三款创新药，首次纳入了国家医保目录；</p><p><strong><span>除此之外，恒瑞医药一共参与了四次仿制药全国集采，</span></strong>第二次～第五次集采一次都没落下，而且按集采相关规定来看，药品集采对业绩影响一般会在半年后兑现，相关药品收入免不了下降50%。</p><p>所以衡量来看，在2021年恒瑞医药业绩没有明显起色的背景下，考虑2021的集采和谈判，我们似乎认为恒瑞医药2022业绩增长仍有着不小压力。</p><p><strong><span>但如果仅仅是这么考虑，我们可能和那些情绪化的投资者没什么区别，而且有点想当然。</span></strong></p><div><img img_height=\"446\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/cb885e7eaa274609b4bf510bba5f8c45\"/></div><p><em>（注明：药品红字部分指恒瑞医药已上市的7款创新药，恒瑞医药目前共有10款创新药。）</em></p><p><strong><span>二、恒瑞医药2022年业绩增长有何支撑？</span></strong></p><p><strong><span>因为细细追究来看，我们会发现，事情并没有那么悲观，</span></strong>对于恒瑞医药来说，这是一个不断进化的过程，且净利率端还有当前较大的研发压力，恒瑞医药厚积薄发还是有希望的。</p><p><strong><span>1、仿制药集采虽会扩容，但“新药”上市速度在加快</span></strong></p><p>虽然2021年上半年第三次集采的六款仿制药收入下降了57%，但整体来看，恒瑞医药的收入仍然是在增长的，<strong><span>这一方面和我们一直说道的创新药上市密切相关，另一方面是因为“新的”仿制药也在不断上市。</span></strong></p><p>即2021年上半年恒瑞医药共有<strong><span>14款</span></strong>药品获得药（产）品注册批件，其中有近三分之二都是仿制药；相对应的2020年全年，恒瑞医药取得创新药制剂生产批件为<strong><span>6个</span></strong>、仿制药制剂生产批件也仅有<strong><span>5个</span></strong>，<strong><span>创新药和仿制药上市速度都在加快。</span></strong></p><p>同时，由2022年新一年的集采计划目标，按品种数量来看，2022年将实施的两次集采的规模或不会小于前五次。</p><p><strong><span>所以对于恒瑞医药来说，虽然已知集采会不断深化，但恒瑞医药有能力维持着仿制药的收入规模不会出现突然大幅度的下滑。实现业绩平滑是恒瑞医药尽快转型的一个重要方式。</span></strong></p><div><img img_height=\"266\" img_width=\"640\" inline=\"0\" src=\"https://static.tigerbbs.com/b60b164dcbec4dc0a1605db34816886c\"/></div><p><strong><span>2、创新药拐点可能要早于业绩拐点</span></strong></p><p>恒瑞医药目前的创新药销售情况就好比狗熊掰棒子，刚上市一个产品可能不到半年就加入医保谈判降价了，<strong><span>但追究下去的话我们会发现要不是前前后后这些创新药撑着局面，恒瑞医药怎么可能维持着业绩的稳定。</span></strong></p><p>2021年上半年恒瑞医药创新药收入占比为39.15%，收入规模同比增长了43.8%，而这半年创新药新上市产品有1种，2020年新加入医保的为1种，一共有8款创新药；</p><p>2021年下半年，恒瑞医药又新上市了两款创新药，同时在医保内的创新药数量增加了3种（均为谈判），一共有10款创新药，因此从“结构”和规模上看都没有太大问题。</p><p><strong><span>值得一提的是，恒瑞医药新上市的两款创新药，达尔西利、恒格列净分别是首个国产CDK4/6抑制剂、首个国产SGLT-2抑制剂，二者研发投入累计超过了6.37亿元，相当于PD-1 40%的研发规模，不容小觑。</span></strong></p><p>因此，对于恒瑞医药来说，当前研发进程仍在持续加快，作为净利润端的一大影响因素，研发费用率的提升甚至比销售费用率的提升以及毛利率的下降幅度还要大，<strong><span>但没有前者的投入，又怎么能带来销售费用率和毛利率的正向改善，这是一个一比二的关系。</span></strong></p><p><strong><span>三、总结一下</span></strong></p><p><strong><span>总的来看，我们对于恒瑞医药的看法始终没有改变，</span></strong>虽然前期因为企业参与集采以及医保降价，基本面发生了一些变化，但股价下挫最主要的原因还在于前期预期太高了，如果之前股价没有透支未来好几年的情况或许股价下跌幅度会小点。</p><p>展望未来，恒瑞医药见到希望的曙光可能不需要太久，既然2021年不行，那我们就等2022年，如果再出现价格更低的情况反而也是好的，但在抄底之前，我们要做好充分的准备！（比如说现金流折现算一下乐观或悲观情况下，恒瑞医药的价值。）</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/769dc8865e0dc507ddea5079c2429001","relate_stocks":{"600276":"恒瑞医药"},"source_url":"https://m.toutiao.com/i7054466291519717921/info/?i=7054466291519717921","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204086873","content_text":"巴菲特曾经说过对于质优股永远不卖，他曾说，如果你给我1000亿美元用以交换可口可乐这种饮料在世界上的领先权，我会把钱还给你，并对你说‘这可不成’。但巴菲特也会说，当人们忘记“二加二等于四”这种最基本的常识时，就该是脱手离场的时候了，伯克希尔的保险子公司也曾通过套利获得了异常巨大的利润。如果将巴菲特的投资原则提炼一下的话，那就是对于有高的竞争壁垒（或者说特许经营权）的企业不会卖出，但也会买卖市场上的价格与价值出现偏离的股票。那这时候我就想到了恒瑞医药，它是属于巴菲特认为的哪一类呢，而显然，在我看来，它一定是属于有高竞争壁垒的前者。我想，投资恒瑞医药的人应该都是这么认为的，只是可能没有投资在好的价格上。话不多说，好久没跟踪恒瑞医药了，我们来看看它现在怎么样了。一、业绩增速放缓仍然刺激着股价短期走势根据业绩预增披露原则，近期已有不少企业陆陆续续披露了业绩预增报告，但对于恒瑞医药来说，今年的业绩预增报告肯定是没戏了（净利润同比增长50%或下降50%以上）。2022年1月13日，随着恒瑞医药在投资互动平台中回复2021年前三季度企业业绩增速放缓原因，恒瑞医药便又迎来了接连几日的下跌，昨日甚至进入到了沪股通成交榜，被净卖出了7252.92万元。许久不见，大家还是那么情绪化。但显然，这些都不能证明恒瑞医药短期的基本面又发生了大的变动，只能说股价因为资金流入上涨、流出下跌是很正常的事情。而且早在2021年，恒瑞医药二季度、三季度业绩便呈现出明显下滑趋势，但它的前十大流通股股东，除了香港中央结算有限公司减持了6.9%之外，其他机构均处于不变甚至增持趋势。对于恒瑞医药来说，近两年医保谈判以及仿制药集采都因药品单价的大幅下跌而给企业业绩带来不小压力。大产品PD-1于2020年年末加入医保降幅近85%，紧接着在2021年年末又有四款药，其中包括三款创新药，首次纳入了国家医保目录；除此之外，恒瑞医药一共参与了四次仿制药全国集采，第二次～第五次集采一次都没落下，而且按集采相关规定来看，药品集采对业绩影响一般会在半年后兑现，相关药品收入免不了下降50%。所以衡量来看，在2021年恒瑞医药业绩没有明显起色的背景下，考虑2021的集采和谈判，我们似乎认为恒瑞医药2022业绩增长仍有着不小压力。但如果仅仅是这么考虑，我们可能和那些情绪化的投资者没什么区别，而且有点想当然。（注明：药品红字部分指恒瑞医药已上市的7款创新药，恒瑞医药目前共有10款创新药。）二、恒瑞医药2022年业绩增长有何支撑？因为细细追究来看，我们会发现，事情并没有那么悲观，对于恒瑞医药来说，这是一个不断进化的过程，且净利率端还有当前较大的研发压力，恒瑞医药厚积薄发还是有希望的。1、仿制药集采虽会扩容，但“新药”上市速度在加快虽然2021年上半年第三次集采的六款仿制药收入下降了57%，但整体来看，恒瑞医药的收入仍然是在增长的，这一方面和我们一直说道的创新药上市密切相关，另一方面是因为“新的”仿制药也在不断上市。即2021年上半年恒瑞医药共有14款药品获得药（产）品注册批件，其中有近三分之二都是仿制药；相对应的2020年全年，恒瑞医药取得创新药制剂生产批件为6个、仿制药制剂生产批件也仅有5个，创新药和仿制药上市速度都在加快。同时，由2022年新一年的集采计划目标，按品种数量来看，2022年将实施的两次集采的规模或不会小于前五次。所以对于恒瑞医药来说，虽然已知集采会不断深化，但恒瑞医药有能力维持着仿制药的收入规模不会出现突然大幅度的下滑。实现业绩平滑是恒瑞医药尽快转型的一个重要方式。2、创新药拐点可能要早于业绩拐点恒瑞医药目前的创新药销售情况就好比狗熊掰棒子，刚上市一个产品可能不到半年就加入医保谈判降价了，但追究下去的话我们会发现要不是前前后后这些创新药撑着局面，恒瑞医药怎么可能维持着业绩的稳定。2021年上半年恒瑞医药创新药收入占比为39.15%，收入规模同比增长了43.8%，而这半年创新药新上市产品有1种，2020年新加入医保的为1种，一共有8款创新药；2021年下半年，恒瑞医药又新上市了两款创新药，同时在医保内的创新药数量增加了3种（均为谈判），一共有10款创新药，因此从“结构”和规模上看都没有太大问题。值得一提的是，恒瑞医药新上市的两款创新药，达尔西利、恒格列净分别是首个国产CDK4/6抑制剂、首个国产SGLT-2抑制剂，二者研发投入累计超过了6.37亿元，相当于PD-1 40%的研发规模，不容小觑。因此，对于恒瑞医药来说，当前研发进程仍在持续加快，作为净利润端的一大影响因素，研发费用率的提升甚至比销售费用率的提升以及毛利率的下降幅度还要大，但没有前者的投入，又怎么能带来销售费用率和毛利率的正向改善，这是一个一比二的关系。三、总结一下总的来看，我们对于恒瑞医药的看法始终没有改变，虽然前期因为企业参与集采以及医保降价，基本面发生了一些变化，但股价下挫最主要的原因还在于前期预期太高了，如果之前股价没有透支未来好几年的情况或许股价下跌幅度会小点。展望未来，恒瑞医药见到希望的曙光可能不需要太久，既然2021年不行，那我们就等2022年，如果再出现价格更低的情况反而也是好的，但在抄底之前，我们要做好充分的准备！（比如说现金流折现算一下乐观或悲观情况下，恒瑞医药的价值。）","news_type":1,"symbols_score_info":{"600276":1}},"isVote":1,"tweetType":1,"viewCount":2406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697110595,"gmtCreate":1642348891810,"gmtModify":1642348892072,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697110595","repostId":"2203742646","repostType":4,"isVote":1,"tweetType":1,"viewCount":2253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697134510,"gmtCreate":1642348361145,"gmtModify":1642348361455,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Hengrui, steady, hope that more good news will come your way!!","listText":"Hengrui, steady, hope that more good news will come your way!!","text":"Hengrui, steady, hope that more good news will come your way!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697134510","repostId":"2193124115","repostType":2,"repost":{"id":"2193124115","kind":"highlight","pubTimestamp":1640332370,"share":"https://www.laohu8.com/m/news/2193124115?lang=zh_CN&edition=full","pubTime":"2021-12-24 15:52","market":"us","language":"zh","title":"恒瑞医药(600276.SH)子公司SHR-1314注射液获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2193124115","media":"智通财经网","summary":"恒瑞医药(600276.SH)发布公告，近日，公司子公司苏州盛迪亚生物医药有限公司...","content":"<html><body><div> <p>智通财经APP讯，<a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>(600276.SH)发布公告，近日，公司子公司苏州盛迪亚生物医药有限公司收到国家药品监督管理局(简称“国家药监局”)核准签发关于SHR-1314注射液的《药物临床试验批准通知书》，将于近期开展临床试验。</p><p>据悉，SHR-1314注射液是公司自主研发的一种靶向人IL-17A的重组人源化单克隆抗体，拟用于治疗与IL-17通路相关的自身免疫疾病。</p> </div></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药(600276.SH)子公司SHR-1314注射液获药物临床试验批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药(600276.SH)子公司SHR-1314注射液获药物临床试验批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 15:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/628596.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，恒瑞医药(600276.SH)发布公告，近日，公司子公司苏州盛迪亚生物医药有限公司收到国家药品监督管理局(简称“国家药监局”)核准签发关于SHR-1314注射液的《药物临床试验批准通知书》，将于近期开展临床试验。据悉，SHR-1314注射液是公司自主研发的一种靶向人IL-17A的重组人源化单克隆抗体，拟用于治疗与IL-17通路相关的自身免疫疾病。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/628596.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","relate_stocks":{"600276":"恒瑞医药","BK1141":"生命科学工具和服务","BK1583":"高瓴概念","BK1576":"医药外包概念","03347":"泰格医药"},"source_url":"http://www.zhitongcaijing.com/content/detail/628596.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2193124115","content_text":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，近日，公司子公司苏州盛迪亚生物医药有限公司收到国家药品监督管理局(简称“国家药监局”)核准签发关于SHR-1314注射液的《药物临床试验批准通知书》，将于近期开展临床试验。据悉，SHR-1314注射液是公司自主研发的一种靶向人IL-17A的重组人源化单克隆抗体，拟用于治疗与IL-17通路相关的自身免疫疾病。","news_type":1,"symbols_score_info":{"600276":1,"03347":1}},"isVote":1,"tweetType":1,"viewCount":2537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697134127,"gmtCreate":1642348302998,"gmtModify":1642348303297,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Congrats for the good news!","listText":"Congrats for the good news!","text":"Congrats for the good news!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697134127","repostId":"2202204789","repostType":2,"repost":{"id":"2202204789","kind":"news","pubTimestamp":1641890451,"share":"https://www.laohu8.com/m/news/2202204789?lang=zh_CN&edition=full","pubTime":"2022-01-11 16:40","market":"hk","language":"zh","title":"恒瑞医药(600276.SH)：恒曲获批开展治疗恶性肿瘤化疗所致血小板减少症Ⅲ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2202204789","media":"智通财经","summary":"智通财经APP讯，恒瑞医药(600276.SH)公告，近日，公司收到美国食品药品监督管理局(“美国FDA”)关于同意海曲泊帕乙醇胺片进行临床试验的函，将于近期开展Ⅲ期临床试验。试验通俗题目：海曲泊帕治疗恶性肿瘤化疗所致血小板减少症的Ⅲ期临床研究试验。据悉，海曲泊帕乙醇胺片(商品名：恒曲)于2021年6月获得国家药品监督管理局批准用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者的治疗，以及用于对免疫抑制治疗疗效不佳的重型再生障碍性贫血成人患者的治疗。","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>(600276.SH)公告，近日，公司收到美国食品药品监督管理局(“美国FDA”)关于同意海曲泊帕乙醇胺片进行临床试验的函，将于近期开展Ⅲ期临床试验。试验通俗题目：海曲泊帕治疗恶性肿瘤化疗所致血小板减少症的Ⅲ期临床研究试验。</p><p>据悉，海曲泊帕乙醇胺片(商品名：恒曲)于2021年6月获得国家药品监督管理局批准用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者的治疗，以及用于对免疫抑制治疗疗效不佳的重型再生障碍性贫血成人患者的治疗。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药(600276.SH)：恒曲获批开展治疗恶性肿瘤化疗所致血小板减少症Ⅲ期临床试验</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药(600276.SH)：恒曲获批开展治疗恶性肿瘤化疗所致血小板减少症Ⅲ期临床试验\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 16:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/638846.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，恒瑞医药(600276.SH)公告，近日，公司收到美国食品药品监督管理局(“美国FDA”)关于同意海曲泊帕乙醇胺片进行临床试验的函，将于近期开展Ⅲ期临床试验。试验通俗题目：海曲泊帕治疗恶性肿瘤化疗所致血小板减少症的Ⅲ期临床研究试验。据悉，海曲泊帕乙醇胺片(商品名：恒曲)于2021年6月获得国家药品监督管理局批准用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/638846.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","relate_stocks":{"600276":"恒瑞医药","BK1141":"生命科学工具和服务","BK1583":"高瓴概念","BK1576":"医药外包概念","03347":"泰格医药"},"source_url":"http://www.zhitongcaijing.com/content/detail/638846.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202204789","content_text":"智通财经APP讯，恒瑞医药(600276.SH)公告，近日，公司收到美国食品药品监督管理局(“美国FDA”)关于同意海曲泊帕乙醇胺片进行临床试验的函，将于近期开展Ⅲ期临床试验。试验通俗题目：海曲泊帕治疗恶性肿瘤化疗所致血小板减少症的Ⅲ期临床研究试验。据悉，海曲泊帕乙醇胺片(商品名：恒曲)于2021年6月获得国家药品监督管理局批准用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者的治疗，以及用于对免疫抑制治疗疗效不佳的重型再生障碍性贫血成人患者的治疗。","news_type":1,"symbols_score_info":{"600276":1,"03347":1}},"isVote":1,"tweetType":1,"viewCount":2720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697134338,"gmtCreate":1642348247088,"gmtModify":1642348247400,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Interesting...&nbsp;","listText":"Interesting...&nbsp;","text":"Interesting...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697134338","repostId":"2203765768","repostType":2,"repost":{"id":"2203765768","kind":"highlight","pubTimestamp":1642066381,"share":"https://www.laohu8.com/m/news/2203765768?lang=zh_CN&edition=full","pubTime":"2022-01-13 17:33","market":"us","language":"zh","title":"【北向资金大单买入报告】恒瑞医药获净卖出7.77亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2203765768","media":"金十数据","summary":"1月13日，北向资金全天大幅净卖出5.86亿元。","content":"<html><body><p>1月13日，北向资金全天大幅<strong>净</strong><strong>卖出5.86亿元</strong>。其中沪股通<strong>净买入14.54亿元</strong>，深股通<strong>净卖出20.4亿元</strong>。</p>\n<p><img src=\"https://flash-scdn.jin10.com/flash_dli/img/7af323c3-f700-4346-bb21-ed290c04a8d1.jpg\"/></p>\n<p>今日，<strong><a href=\"https://laohu8.com/S/600519\">贵州茅台</a></strong>、<strong><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></strong>等个股上榜沪股通十大成交活跃股。其中<strong><a href=\"https://laohu8.com/S/600406\">国电南瑞</a></strong>、<strong><a href=\"https://laohu8.com/S/WX\">药明康德</a></strong>、<strong><a href=\"https://laohu8.com/S/601012\">隆基股份</a></strong>、<strong><a href=\"https://laohu8.com/S/600036\">招商银行</a></strong>、<strong><a href=\"https://laohu8.com/S/601318\">中国平安</a></strong>、<strong><a href=\"https://laohu8.com/S/601899\">紫金矿业</a></strong>、<strong><a href=\"https://laohu8.com/S/603799\">华友钴业</a></strong>、<strong>贵州茅台</strong>分别被净买入5.83亿元、3.81亿元、3.67亿元、2.89亿元、2.71亿元、2亿元、1.3亿元、0.76亿元；<strong>恒瑞医药</strong>、<strong>中国巨石</strong>分别被净卖出7.77亿元、5亿元。</p>\n<p><img src=\"https://flash-scdn.jin10.com/flash_dli/img/9143a974-adef-4255-bf81-959f0851c21c.jpg\"/></p>\n<p>深市方面，<strong><a href=\"https://laohu8.com/S/300750\">宁德时代</a></strong>、<strong><a href=\"https://laohu8.com/S/002594\">比亚迪</a></strong>等个股今日上榜深股通十大成交活跃股，其中<strong><a href=\"https://laohu8.com/S/002812\">恩捷股份</a></strong>、<strong><a href=\"https://laohu8.com/S/300014\">亿纬锂能</a></strong>、<strong><a href=\"https://laohu8.com/S/002460\">赣锋锂业</a></strong>分别被净买入3.73亿元、2.71亿元、2.49亿元；<strong><a href=\"https://laohu8.com/S/300015\">爱尔眼科</a></strong>、<strong>比亚迪</strong>、<strong><a href=\"https://laohu8.com/S/000858\">五粮液</a></strong>、<strong>宁德时代</strong>、<strong>东方财富</strong>、<strong><a href=\"https://laohu8.com/S/002475\">立讯精密</a></strong>、<strong><a href=\"https://laohu8.com/S/300760\">迈瑞医疗</a></strong>分别被净卖出5.65亿元、2.86亿元、2.26亿元、2.19亿元、0.48亿元、0.32亿元、0.28亿元。</p>\n<p><img src=\"https://flash-scdn.jin10.com/flash_dli/img/e15a5c34-008a-47c0-9387-512b8391cfa3.jpg\"/></p></body></html>","source":"xnew_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【北向资金大单买入报告】恒瑞医药获净卖出7.77亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【北向资金大单买入报告】恒瑞医药获净卖出7.77亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 17:33 北京时间&nbsp;&nbsp;&nbsp;<a href=https://xnews.jin10.com/webapp/details.html?id=88822&type=news><strong>金十数据</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1月13日，北向资金全天大幅净卖出5.86亿元。其中沪股通净买入14.54亿元，深股通净卖出20.4亿元。\n\n今日，贵州茅台、恒瑞医药等个股上榜沪股通十大成交活跃股。其中国电南瑞、药明康德、隆基股份、招商银行、中国平安、紫金矿业、华友钴业、贵州茅台分别被净买入5.83亿元、3.81亿元、3.67亿元、2.89亿元、2.71亿元、2亿元、1.3亿元、0.76亿元；恒瑞医药、中国巨石分别被净卖出...</p>\n\n<a href=\"https://xnews.jin10.com/webapp/details.html?id=88822&type=news\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://cdn.jin10.com/assets/img/long_pic/cover3.jpg/lite","relate_stocks":{"600276":"恒瑞医药"},"source_url":"https://xnews.jin10.com/webapp/details.html?id=88822&type=news","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203765768","content_text":"1月13日，北向资金全天大幅净卖出5.86亿元。其中沪股通净买入14.54亿元，深股通净卖出20.4亿元。\n\n今日，贵州茅台、恒瑞医药等个股上榜沪股通十大成交活跃股。其中国电南瑞、药明康德、隆基股份、招商银行、中国平安、紫金矿业、华友钴业、贵州茅台分别被净买入5.83亿元、3.81亿元、3.67亿元、2.89亿元、2.71亿元、2亿元、1.3亿元、0.76亿元；恒瑞医药、中国巨石分别被净卖出7.77亿元、5亿元。\n\n深市方面，宁德时代、比亚迪等个股今日上榜深股通十大成交活跃股，其中恩捷股份、亿纬锂能、赣锋锂业分别被净买入3.73亿元、2.71亿元、2.49亿元；爱尔眼科、比亚迪、五粮液、宁德时代、东方财富、立讯精密、迈瑞医疗分别被净卖出5.65亿元、2.86亿元、2.26亿元、2.19亿元、0.48亿元、0.32亿元、0.28亿元。","news_type":1,"symbols_score_info":{"600276":1}},"isVote":1,"tweetType":1,"viewCount":2959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697135734,"gmtCreate":1642348107918,"gmtModify":1642348108221,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Wow...","listText":"Wow...","text":"Wow...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697135734","repostId":"2203564766","repostType":2,"repost":{"id":"2203564766","kind":"news","pubTimestamp":1642068120,"share":"https://www.laohu8.com/m/news/2203564766?lang=zh_CN&edition=full","pubTime":"2022-01-13 18:02","market":"hk","language":"zh","title":"北水连续第8日加仓美团，今日再大幅买入超8亿港元；南水抛售恒瑞医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2203564766","media":"富途牛牛","summary":"南向资金今日净买入13.39亿港元，连续7日净买入。融创中国、美团-W、快手-W分别获净买入8.62亿港元、8.21亿港元、3.4亿港元。香港交易所净卖出额居首，金额为5.79亿港元。南下资金已连续8日净买入美团，累计买入约41.655亿港元。北向资金今日小幅净卖出5.85亿元，恒瑞医药、爱尔眼科、中国巨石分别遭净卖出7.77亿元、5.65亿元、5亿元。净买入方面，国电南瑞、药明康德、恩捷股份净买入额位列前三，分别获净买入5.83亿元、3.81亿元、3.73亿元。编辑/irisz","content":"<html><body><article><p>南向资金今日净买入13.39亿港元，连续7日净买入。<a href=\"https://laohu8.com/S/01918\">融创中国</a>、<a href=\"https://laohu8.com/S/03690\">美团-W</a>、<a href=\"https://laohu8.com/S/01024\">快手-W</a>分别获净买入8.62亿港元、8.21亿港元、3.4亿港元。<a href=\"https://laohu8.com/S/00388\">香港交易所</a>净卖出额居首，金额为5.79亿港元。</p><p>南下资金已连续8日净买入美团，累计买入约41.655亿港元。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20220113180313571v154ec5y7bejsb4\"/><p>北向资金今日小幅净卖出5.85亿元，<a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>、<a href=\"https://laohu8.com/S/300015\">爱尔眼科</a>、<a href=\"https://laohu8.com/S/600176\">中国巨石</a>分别遭净卖出7.77亿元、5.65亿元、5亿元。净买入方面，国电南瑞、<a href=\"https://laohu8.com/S/WX\">药明康德</a>、<a href=\"https://laohu8.com/S/002812\">恩捷股份</a>净买入额位列前三，分别获净买入5.83亿元、3.81亿元、3.73亿元。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20220113180326335v154zowqxjxkmx7\"/><p>编辑/irisz</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>北水连续第8日加仓美团，今日再大幅买入超8亿港元；南水抛售恒瑞医药</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n北水连续第8日加仓美团，今日再大幅买入超8亿港元；南水抛售恒瑞医药\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 18:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201131803277c6a8b02&s=b><strong>富途牛牛</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>南向资金今日净买入13.39亿港元，连续7日净买入。融创中国、美团-W、快手-W分别获净买入8.62亿港元、8.21亿港元、3.4亿港元。香港交易所净卖出额居首，金额为5.79亿港元。南下资金已连续8日净买入美团，累计买入约41.655亿港元。北向资金今日小幅净卖出5.85亿元，恒瑞医药、爱尔眼科、中国巨石分别遭净卖出7.77亿元、5.65亿元、5亿元。净买入方面，国电南瑞、药明康德、恩捷股份净...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201131803277c6a8b02&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28","relate_stocks":{"600276":"恒瑞医药","BK1583":"高瓴概念","BK1604":"节假日概念","03690":"美团-W","BK1589":"北水核心资产","BK1521":"挪威政府全球养老基金持仓","BK1591":"就地过年概念","BK1575":"同股不同权","BK1142":"互联网与直销零售"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201131803277c6a8b02&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2203564766","content_text":"南向资金今日净买入13.39亿港元，连续7日净买入。融创中国、美团-W、快手-W分别获净买入8.62亿港元、8.21亿港元、3.4亿港元。香港交易所净卖出额居首，金额为5.79亿港元。南下资金已连续8日净买入美团，累计买入约41.655亿港元。北向资金今日小幅净卖出5.85亿元，恒瑞医药、爱尔眼科、中国巨石分别遭净卖出7.77亿元、5.65亿元、5亿元。净买入方面，国电南瑞、药明康德、恩捷股份净买入额位列前三，分别获净买入5.83亿元、3.81亿元、3.73亿元。编辑/irisz","news_type":1,"symbols_score_info":{"48457":0.9,"48459":0.6,"48476":0.6,"600276":1,"03690":1}},"isVote":1,"tweetType":1,"viewCount":2243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697135585,"gmtCreate":1642347979897,"gmtModify":1642347980167,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Good news!!!","listText":"Good news!!!","text":"Good news!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697135585","repostId":"2203713101","repostType":2,"repost":{"id":"2203713101","kind":"news","pubTimestamp":1642148192,"share":"https://www.laohu8.com/m/news/2203713101?lang=zh_CN&edition=full","pubTime":"2022-01-14 16:16","market":"hk","language":"zh","title":"恒瑞医药(600276.SH)SHR8008胶囊的药品上市许可申请获药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2203713101","media":"智通财经","summary":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，公司收到国家药品监督管理局(以下简称“药监局”)下发的《受理通知书》，公司提交的SHR8008胶囊的药品上市许可申请获药监局受理。SHR8008是一种新型口服唑类抗真菌药物，可高度特异性抑制真菌CYP51酶，在国外已经完成1项针对急性外阴阴道假丝酵母菌病的临床Ⅱ期研究、1项针对复发性外阴阴道假丝酵母菌病的临床Ⅱ期研究和3项针对复发性外阴阴道假丝酵母菌病的临床Ⅲ期研究。","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>(600276.SH)发布公告，公司收到国家药品监督管理局(以下简称“药监局”)下发的《受理通知书》，公司提交的SHR8008胶囊的药品上市许可申请获药监局受理。</p><p>SHR8008是一种新型口服唑类抗真菌药物，可高度特异性抑制真菌CYP51酶，在国外已经完成1项针对急性外阴阴道假丝酵母菌病的临床Ⅱ期研究、1项针对复发性外阴阴道假丝酵母菌病的临床Ⅱ期研究和3项针对复发性外阴阴道假丝酵母菌病的临床Ⅲ期研究。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药(600276.SH)SHR8008胶囊的药品上市许可申请获药监局受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药(600276.SH)SHR8008胶囊的药品上市许可申请获药监局受理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 16:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/640992.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，恒瑞医药(600276.SH)发布公告，公司收到国家药品监督管理局(以下简称“药监局”)下发的《受理通知书》，公司提交的SHR8008胶囊的药品上市许可申请获药监局受理。SHR8008是一种新型口服唑类抗真菌药物，可高度特异性抑制真菌CYP51酶，在国外已经完成1项针对急性外阴阴道假丝酵母菌病的临床Ⅱ期研究、1项针对复发性外阴阴道假丝酵母菌病的临床Ⅱ期研究和3项针对复发性外阴阴道...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/640992.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","relate_stocks":{"600276":"恒瑞医药"},"source_url":"http://www.zhitongcaijing.com/content/detail/640992.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203713101","content_text":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，公司收到国家药品监督管理局(以下简称“药监局”)下发的《受理通知书》，公司提交的SHR8008胶囊的药品上市许可申请获药监局受理。SHR8008是一种新型口服唑类抗真菌药物，可高度特异性抑制真菌CYP51酶，在国外已经完成1项针对急性外阴阴道假丝酵母菌病的临床Ⅱ期研究、1项针对复发性外阴阴道假丝酵母菌病的临床Ⅱ期研究和3项针对复发性外阴阴道假丝酵母菌病的临床Ⅲ期研究。","news_type":1,"symbols_score_info":{"600276":1}},"isVote":1,"tweetType":1,"viewCount":2429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600282060,"gmtCreate":1638157965152,"gmtModify":1638157965276,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600282060","repostId":"1124072014","repostType":4,"repost":{"id":"1124072014","kind":"news","pubTimestamp":1638140765,"share":"https://www.laohu8.com/m/news/1124072014?lang=zh_CN&edition=full","pubTime":"2021-11-29 07:06","market":"us","language":"en","title":"November jobs report: What to know this week<blockquote>11月就业报告：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1124072014","media":"yahoo","summary":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor","content":"<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.</p><p><blockquote>随着投资者从感恩节缩短的交易周回归，焦点将转向美国劳动力市场。</blockquote></p><p> The Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.</p><p><blockquote>美国劳工部将于周五发布的月度就业报告将提供美国经济中招聘和劳动力参与实力的最新快照。经济学家一致认为，11月份将有50万个工作岗位回归，招聘速度仅较10月份的531,000个略有放缓。失业率也有望从10月的4.6%进一步改善至4.5%，达到2020年3月以来的最低水平。</blockquote></p><p> \"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.</p><p><blockquote>凯投宏观(Capital Economics)首席北美经济学家保罗·阿什沃斯(Paul Ashworth)写道：“我们预计11月份非农就业人数将增加50万人，但冬季新冠疫情风险不断增加以及可用工人供应减少将很快拖累就业增长。”，在上周的一份报告中。</blockquote></p><p> \"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply could<i>worsen</i>over the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"</p><p><blockquote>“除非劳动力出现更显著的复苏，否则就业增长不可能以这种速度持续太久。如果说有什么不同的话，那就是劳动力供应可以<i>恶化</i>随着覆盖1亿工人的联邦疫苗授权于1月4日开始，未来几个月，”阿什沃斯补充道。“这表明工资增长将保持强劲，我们预计10月份平均时薪将[环比]增长0.4%。”</blockquote></p><p> On a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.</p><p><blockquote>与去年同期相比，平均时薪预计将增长5.0%，继10月份已经显着增长4.9%之后进一步加速，这是自2月份以来最快的工资增长率。</blockquote></p><p> Growing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.</p><p><blockquote>平均工资增长和劳动力市场紧张虽然对消费者及其消费能力有利，但也引发了人们对持续通胀的担忧。上周经济分析局公布的10月份个人消费支出(PCE)平减指数显示，该指数年率上涨5.0%，创1990年以来最大涨幅。核心PCE（即美联储首选的剔除波动较大的食品和能源价格的通胀指标）同比上涨4.1%，为三十年来的最高水平。</blockquote></p><p> Other recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.</p><p><blockquote>最近的其他数据集中在紧张的劳动力市场上，并预示着11月份就业报告可能强劲。上周首次申请失业救济人数降至19.9万人的52年低点，打破了之前大流行时期的低点和大流行前新首次申请失业救济人数的平均值。这再次凸显了美国雇主之间对劳动力的激烈竞争，在劳动力普遍短缺的情况下，公司试图雇用和留住现有劳动力。</blockquote></p><p> Even given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.</p><p><blockquote>即使考虑到这些挥之不去的短缺，劳动力参与率仍未恢复到大流行前的水平。与2020年2月相比，平民劳动力仍减少了近300万参与者，对病毒的担忧挥之不去，许多工作年龄的人渴望寻找具有更好灵活性和福利的新角色，这仍然使许多人处于劳动力的边缘。经济学家普遍预计，11月份劳动力参与率仅略有上升，达到61.7%，高于10月份的61.6%，但远低于2020年2月的63.3%。</blockquote></p><p> Returning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.</p><p><blockquote>让经济回到大流行前的劳动力参与水平，并确保不同群体公平地看到就业增长，已成为美联储的一个重点关注点。在这些方面仍有待弥补的距离也是美联储货币政策支持保持超宽松的最大因素，即使在一系列高于预期的通胀报告似乎需要采取更强硬的政策倾斜美联储主席杰罗姆·鲍威尔再次被提名继续担任央行行长进一步表明，美联储将继续关注劳动力市场，将其作为货币政策的关键信息因素。</blockquote></p><p> \"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"</p><p><blockquote>德意志银行经济学家贾斯汀·魏德纳(Justin Weidner)上周在一份报告中写道：“由于有证据表明通胀压力上升可能会持续更长时间，市场对美联储未来加息的看法已大幅提前。”“然而，正如鲍威尔主席11月新闻发布会所表明的那样，劳动力市场恢复最大就业的前景仍然是美联储最终何时开始积极收紧货币政策的关键考虑因素。”</blockquote></p><p> Economic calendar</p><p><blockquote>经济日历</blockquote></p><p> <ul>  <li><b>Monday:</b>Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)</p><p><blockquote><ul><li><b>星期一：</b>10月份待售房屋环比（预期0.7%，9月份-2.3%）；11月达拉斯联储制造业活动指数（预期17.0，10月14.6）</li></ul></blockquote></p><p></p><p></li>  <li><b>Tuesday:</b>FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)</p><p><blockquote><li><b>星期二：</b>9月FHFA房价指数环比（预期为1.2%，8月为1.0%）；S&amp;P CoreLogic Case-Shiller 20城综合指数，9月环比（预期1.30%，8月1.17%）；S&amp;P CoreLogic Case-Shiller 20城市综合指数，9月（上月为19.66%）；11月MNI芝加哥PMI（预期67.0，10月68.4）；世界大型企业联合会11月消费者信心指数（预期110.0，10月113.8）</li></blockquote></p><p></li>  <li><b>Wednesday:</b>MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book</p><p><blockquote><li><b>星期三：</b>MBA抵押贷款申请，11月26日（前一周为1.8%）；11月ADP就业变化（预期51.5万人，10月57.1万人）；Markit美国制造业PMI，11月终值（上月为59.1）；10月份建筑支出环比（预期0.5%，9月份-0.5%）；ISM制造业，11月（预期61.0，10月60.8）；美联储发布褐皮书</li></blockquote></p><p></li>  <li><b>Thursday:</b>Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)</p><p><blockquote><li><b>星期四：</b>挑战者裁员，11月（10月-71.7%）；截至11月27日当周首次申请失业救济人数（前一周为199,000人）；11月20日持续申请失业救济人数（前一周为2.049）</li></blockquote></p><p></li>  <li><b>Friday:</b>Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)</p><p><blockquote><li><b>星期五：</b>11月非农就业人数变化（预期50万，10月53.1万）；11月失业率（预期4.5%，10月4.6%）；11月平均时薪环比（预期0.4%，10月0.4%）；11月平均时薪同比（预期5.0%，10月4.9%）；Markit美国服务业PMI，11月最终数据（上一期为57.0）；Markit美国综合PMI，11月最终数据（上一期为56.5）；ISM服务业指数，11月（预期65.0，10月66.7）；10月工厂订单（预期0.5%，9月0.2%）；耐用品订单，10月份最终（上次打印为-0.5%）</li></blockquote></p><p></li> </ul> Earnings calendar</p><p><blockquote>盈利日历</blockquote></p><p> <ul>  <li><b>Monday:</b><i>No notable reports scheduled for release</i></p><p><blockquote><ul><li><b>星期一：</b><i>没有计划发布值得注意的报告</i></li></ul></blockquote></p><p></li>  <li><b>Tuesday:</b>Salesforce.com (CRM) after market close</p><p><blockquote><li><b>星期二：</b>Salesforce.com(CRM)收盘后</li></blockquote></p><p></li>  <li><b>Wednesday:</b>PVH Corp. (PVH) after market close</p><p><blockquote><li><b>星期三：</b>PVH Corp.(PVH)收盘后</li></blockquote></p><p></li>  <li><b>Thursday:</b>Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close</p><p><blockquote><li><b>星期四：</b>Dollar General(DG)、Kroger(KR)开盘前；Ulta Beauty(ULTA)收盘后</li></blockquote></p><p></li>  <li><b>Friday:</b><i>No notable reports scheduled for release</i></p><p><blockquote><li><b>星期五：</b><i>没有计划发布值得注意的报告</i></li></blockquote></p><p></li> </ul></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>November jobs report: What to know this week<blockquote>11月就业报告：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovember jobs report: What to know this week<blockquote>11月就业报告：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">yahoo</strong><span class=\"h-time small\">2021-11-29 07:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.</p><p><blockquote>随着投资者从感恩节缩短的交易周回归，焦点将转向美国劳动力市场。</blockquote></p><p> The Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.</p><p><blockquote>美国劳工部将于周五发布的月度就业报告将提供美国经济中招聘和劳动力参与实力的最新快照。经济学家一致认为，11月份将有50万个工作岗位回归，招聘速度仅较10月份的531,000个略有放缓。失业率也有望从10月的4.6%进一步改善至4.5%，达到2020年3月以来的最低水平。</blockquote></p><p> \"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.</p><p><blockquote>凯投宏观(Capital Economics)首席北美经济学家保罗·阿什沃斯(Paul Ashworth)写道：“我们预计11月份非农就业人数将增加50万人，但冬季新冠疫情风险不断增加以及可用工人供应减少将很快拖累就业增长。”，在上周的一份报告中。</blockquote></p><p> \"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply could<i>worsen</i>over the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"</p><p><blockquote>“除非劳动力出现更显著的复苏，否则就业增长不可能以这种速度持续太久。如果说有什么不同的话，那就是劳动力供应可以<i>恶化</i>随着覆盖1亿工人的联邦疫苗授权于1月4日开始，未来几个月，”阿什沃斯补充道。“这表明工资增长将保持强劲，我们预计10月份平均时薪将[环比]增长0.4%。”</blockquote></p><p> On a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.</p><p><blockquote>与去年同期相比，平均时薪预计将增长5.0%，继10月份已经显着增长4.9%之后进一步加速，这是自2月份以来最快的工资增长率。</blockquote></p><p> Growing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.</p><p><blockquote>平均工资增长和劳动力市场紧张虽然对消费者及其消费能力有利，但也引发了人们对持续通胀的担忧。上周经济分析局公布的10月份个人消费支出(PCE)平减指数显示，该指数年率上涨5.0%，创1990年以来最大涨幅。核心PCE（即美联储首选的剔除波动较大的食品和能源价格的通胀指标）同比上涨4.1%，为三十年来的最高水平。</blockquote></p><p> Other recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.</p><p><blockquote>最近的其他数据集中在紧张的劳动力市场上，并预示着11月份就业报告可能强劲。上周首次申请失业救济人数降至19.9万人的52年低点，打破了之前大流行时期的低点和大流行前新首次申请失业救济人数的平均值。这再次凸显了美国雇主之间对劳动力的激烈竞争，在劳动力普遍短缺的情况下，公司试图雇用和留住现有劳动力。</blockquote></p><p> Even given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.</p><p><blockquote>即使考虑到这些挥之不去的短缺，劳动力参与率仍未恢复到大流行前的水平。与2020年2月相比，平民劳动力仍减少了近300万参与者，对病毒的担忧挥之不去，许多工作年龄的人渴望寻找具有更好灵活性和福利的新角色，这仍然使许多人处于劳动力的边缘。经济学家普遍预计，11月份劳动力参与率仅略有上升，达到61.7%，高于10月份的61.6%，但远低于2020年2月的63.3%。</blockquote></p><p> Returning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.</p><p><blockquote>让经济回到大流行前的劳动力参与水平，并确保不同群体公平地看到就业增长，已成为美联储的一个重点关注点。在这些方面仍有待弥补的距离也是美联储货币政策支持保持超宽松的最大因素，即使在一系列高于预期的通胀报告似乎需要采取更强硬的政策倾斜美联储主席杰罗姆·鲍威尔再次被提名继续担任央行行长进一步表明，美联储将继续关注劳动力市场，将其作为货币政策的关键信息因素。</blockquote></p><p> \"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"</p><p><blockquote>德意志银行经济学家贾斯汀·魏德纳(Justin Weidner)上周在一份报告中写道：“由于有证据表明通胀压力上升可能会持续更长时间，市场对美联储未来加息的看法已大幅提前。”“然而，正如鲍威尔主席11月新闻发布会所表明的那样，劳动力市场恢复最大就业的前景仍然是美联储最终何时开始积极收紧货币政策的关键考虑因素。”</blockquote></p><p> Economic calendar</p><p><blockquote>经济日历</blockquote></p><p> <ul>  <li><b>Monday:</b>Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)</p><p><blockquote><ul><li><b>星期一：</b>10月份待售房屋环比（预期0.7%，9月份-2.3%）；11月达拉斯联储制造业活动指数（预期17.0，10月14.6）</li></ul></blockquote></p><p></p><p></li>  <li><b>Tuesday:</b>FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)</p><p><blockquote><li><b>星期二：</b>9月FHFA房价指数环比（预期为1.2%，8月为1.0%）；S&amp;P CoreLogic Case-Shiller 20城综合指数，9月环比（预期1.30%，8月1.17%）；S&amp;P CoreLogic Case-Shiller 20城市综合指数，9月（上月为19.66%）；11月MNI芝加哥PMI（预期67.0，10月68.4）；世界大型企业联合会11月消费者信心指数（预期110.0，10月113.8）</li></blockquote></p><p></li>  <li><b>Wednesday:</b>MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book</p><p><blockquote><li><b>星期三：</b>MBA抵押贷款申请，11月26日（前一周为1.8%）；11月ADP就业变化（预期51.5万人，10月57.1万人）；Markit美国制造业PMI，11月终值（上月为59.1）；10月份建筑支出环比（预期0.5%，9月份-0.5%）；ISM制造业，11月（预期61.0，10月60.8）；美联储发布褐皮书</li></blockquote></p><p></li>  <li><b>Thursday:</b>Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)</p><p><blockquote><li><b>星期四：</b>挑战者裁员，11月（10月-71.7%）；截至11月27日当周首次申请失业救济人数（前一周为199,000人）；11月20日持续申请失业救济人数（前一周为2.049）</li></blockquote></p><p></li>  <li><b>Friday:</b>Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)</p><p><blockquote><li><b>星期五：</b>11月非农就业人数变化（预期50万，10月53.1万）；11月失业率（预期4.5%，10月4.6%）；11月平均时薪环比（预期0.4%，10月0.4%）；11月平均时薪同比（预期5.0%，10月4.9%）；Markit美国服务业PMI，11月最终数据（上一期为57.0）；Markit美国综合PMI，11月最终数据（上一期为56.5）；ISM服务业指数，11月（预期65.0，10月66.7）；10月工厂订单（预期0.5%，9月0.2%）；耐用品订单，10月份最终（上次打印为-0.5%）</li></blockquote></p><p></li> </ul> Earnings calendar</p><p><blockquote>盈利日历</blockquote></p><p> <ul>  <li><b>Monday:</b><i>No notable reports scheduled for release</i></p><p><blockquote><ul><li><b>星期一：</b><i>没有计划发布值得注意的报告</i></li></ul></blockquote></p><p></li>  <li><b>Tuesday:</b>Salesforce.com (CRM) after market close</p><p><blockquote><li><b>星期二：</b>Salesforce.com(CRM)收盘后</li></blockquote></p><p></li>  <li><b>Wednesday:</b>PVH Corp. (PVH) after market close</p><p><blockquote><li><b>星期三：</b>PVH Corp.(PVH)收盘后</li></blockquote></p><p></li>  <li><b>Thursday:</b>Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close</p><p><blockquote><li><b>星期四：</b>Dollar General(DG)、Kroger(KR)开盘前；Ulta Beauty(ULTA)收盘后</li></blockquote></p><p></li>  <li><b>Friday:</b><i>No notable reports scheduled for release</i></p><p><blockquote><li><b>星期五：</b><i>没有计划发布值得注意的报告</i></li></blockquote></p><p></li> </ul></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html\">yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时"},"source_url":"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124072014","content_text":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.\n\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.\n\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply couldworsenover the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"\nOn a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.\nGrowing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.\nOther recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.\nEven given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.\nReturning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.\n\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"\nEconomic calendar\n\nMonday:Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)\nTuesday:FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)\nWednesday:MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book\nThursday:Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)\nFriday:Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)\n\nEarnings calendar\n\nMonday:No notable reports scheduled for release\nTuesday:Salesforce.com (CRM) after market close\nWednesday:PVH Corp. (PVH) after market close\nThursday:Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close\nFriday:No notable reports scheduled for release","news_type":1,"symbols_score_info":{"CRM":0.9}},"isVote":1,"tweetType":1,"viewCount":2208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873524468,"gmtCreate":1636965428451,"gmtModify":1636965428883,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Interesting... Will included in my watchlist&nbsp;","listText":"Interesting... Will included in my watchlist&nbsp;","text":"Interesting... Will included in my watchlist","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873524468","repostId":"2178368602","repostType":2,"isVote":1,"tweetType":1,"viewCount":2715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870762154,"gmtCreate":1636649014814,"gmtModify":1636649015297,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Good job","listText":"Good job","text":"Good job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870762154","repostId":"2180682817","repostType":2,"repost":{"id":"2180682817","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1635970475,"share":"https://www.laohu8.com/m/news/2180682817?lang=zh_CN&edition=full","pubTime":"2021-11-04 04:14","market":"us","language":"en","title":"CRISPR Therapeutics Q3 Sales $300.00K Up From $148.00K YoY<blockquote>CRISPR Therapeutics第三季度销售额从去年同期的148.00千美元增加到300.00千美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2180682817","media":"Benzinga","summary":"CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.","content":"<p><html><body>CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.</p><p><blockquote><html><body>CRISPR Therapeutics（纳斯达克：CRSP）报告本季度销售额为30万美元。这比去年同期14.8万美元的销售额增长了102.70%。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CRISPR Therapeutics Q3 Sales $300.00K Up From $148.00K YoY<blockquote>CRISPR Therapeutics第三季度销售额从去年同期的148.00千美元增加到300.00千美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCRISPR Therapeutics Q3 Sales $300.00K Up From $148.00K YoY<blockquote>CRISPR Therapeutics第三季度销售额从去年同期的148.00千美元增加到300.00千美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-11-04 04:14</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body>CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.</p><p><blockquote><html><body>CRISPR Therapeutics（纳斯达克：CRSP）报告本季度销售额为30万美元。这比去年同期14.8万美元的销售额增长了102.70%。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG"},"source_url":"https://www.benzinga.com/news/earnings/21/11/23872086/crispr-therapeutics-q3-sales-300-00k-up-from-148-00k-yoy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180682817","content_text":"CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.","news_type":1,"symbols_score_info":{"CRSP":0.9}},"isVote":1,"tweetType":1,"viewCount":1892,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870667736,"gmtCreate":1636613181375,"gmtModify":1636613181532,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Will see how the result goes in next quarter...","listText":"Will see how the result goes in next quarter...","text":"Will see how the result goes in next quarter...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870667736","repostId":"1101863758","repostType":4,"repost":{"id":"1101863758","kind":"news","pubTimestamp":1636610470,"share":"https://www.laohu8.com/m/news/1101863758?lang=zh_CN&edition=full","pubTime":"2021-11-11 14:01","market":"us","language":"en","title":"Why Palantir Stock Dropped on Wednesday<blockquote>为什么Palantir股价周三下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101863758","media":"Motley Fool","summary":"What happened\nShares of Palantir Technologies fell 7% on Wednesday, following bearish analyst commen","content":"<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of Palantir Technologies&nbsp;fell 7% on Wednesday, following bearish analyst commentary.</p><p><blockquote>在分析师发表看跌评论后，Palantir Technologies股价周三下跌7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/13f94be27affe668764a0a9f5a12d01f\" tg-width=\"881\" tg-height=\"642\" width=\"100%\" height=\"auto\">So what</p><p><blockquote>那又怎样</blockquote></p><p> Palantir's revenue climbed 36% year over year to $392 million in the third quarter. That marked a notable deceleration from the 49% growth the data software provider delivered in the second quarter.</p><p><blockquote>Palantir第三季度营收同比增长36%至3.92亿美元。这标志着该数据软件提供商第二季度49%的增长明显放缓。</blockquote></p><p> The slowdown was enough for RBC Capital analyst Rishi Jaluria to cut his rating on Palantir's stock from sector perform to underperform and slash his share price forecast from $25 to $19.</p><p><blockquote>经济放缓足以让RBC Capital分析师Rishi Jaluria将Palantir股票评级从行业表现下调至表现不佳，并将股价预测从25美元下调至19美元。</blockquote></p><p> Jaluria was particularly concerned with the decline in Palantir's revenue growth rate in its core government business, which fell to 34% from 66% in the second quarter. \"We believe Palantir got direct benefits from COVID-related spending and those benefits have already faded,\" Jaluria said.</p><p><blockquote>Jaluria特别关注Palantir核心政府业务收入增长率的下降，从第二季度的66%降至34%。Jaluria表示：“我们相信Palantir从与新冠病毒相关的支出中获得了直接好处，但这些好处已经消退。”</blockquote></p><p> Moreover, although Palantir saw its U.S. commercial revenue rise by an impressive 103% in the third quarter, Jaluria argued that this level of growth is unsustainable. He noted that Palantir's commercial business has benefited from its strategy of investing in newly public companies in exchange for them agreeing to use its software. Jaluria believes these investments will have less of an impact over time.</p><p><blockquote>此外，尽管Palantir第三季度美国商业收入增长了令人印象深刻的103%，但Jaluria认为这种增长水平是不可持续的。他指出，Palantir的商业业务受益于其投资新上市公司以换取它们同意使用其软件的策略。Jaluria认为，随着时间的推移，这些投资的影响会越来越小。</blockquote></p><p> For these reasons, Jaluria is now less confident that Palantir can achieve its revenue growth target of at least 30% annually through 2025.</p><p><blockquote>出于这些原因，Jaluria现在对Palantir能否实现到2025年每年至少30%的收入增长目标信心不足。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> As a premium-priced growth stock, Palantir is highly exposed to anything that would make investors question whether it can reach its long-term expansion goals. Even after today's stock price decline, Palantir's shares trade for more than 100 times its projected earnings in 2022. Thus, should more analysts raise concerns about its growth projections, Palantir's share price could have further to fall.</p><p><blockquote>作为一只溢价成长型股票，Palantir很容易受到任何会让投资者质疑其能否实现长期扩张目标的影响。即使在今天的股价下跌之后，Palantir的股价仍是其2022年预计收益的100多倍。因此，如果更多分析师对其增长预测表示担忧，Palantir的股价可能会进一步下跌。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Stock Dropped on Wednesday<blockquote>为什么Palantir股价周三下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Stock Dropped on Wednesday<blockquote>为什么Palantir股价周三下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-11-11 14:01</span>\n</p>\n</h4>\n</header>\n<article>\n<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of Palantir Technologies&nbsp;fell 7% on Wednesday, following bearish analyst commentary.</p><p><blockquote>在分析师发表看跌评论后，Palantir Technologies股价周三下跌7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/13f94be27affe668764a0a9f5a12d01f\" tg-width=\"881\" tg-height=\"642\" width=\"100%\" height=\"auto\">So what</p><p><blockquote>那又怎样</blockquote></p><p> Palantir's revenue climbed 36% year over year to $392 million in the third quarter. That marked a notable deceleration from the 49% growth the data software provider delivered in the second quarter.</p><p><blockquote>Palantir第三季度营收同比增长36%至3.92亿美元。这标志着该数据软件提供商第二季度49%的增长明显放缓。</blockquote></p><p> The slowdown was enough for RBC Capital analyst Rishi Jaluria to cut his rating on Palantir's stock from sector perform to underperform and slash his share price forecast from $25 to $19.</p><p><blockquote>经济放缓足以让RBC Capital分析师Rishi Jaluria将Palantir股票评级从行业表现下调至表现不佳，并将股价预测从25美元下调至19美元。</blockquote></p><p> Jaluria was particularly concerned with the decline in Palantir's revenue growth rate in its core government business, which fell to 34% from 66% in the second quarter. \"We believe Palantir got direct benefits from COVID-related spending and those benefits have already faded,\" Jaluria said.</p><p><blockquote>Jaluria特别关注Palantir核心政府业务收入增长率的下降，从第二季度的66%降至34%。Jaluria表示：“我们相信Palantir从与新冠病毒相关的支出中获得了直接好处，但这些好处已经消退。”</blockquote></p><p> Moreover, although Palantir saw its U.S. commercial revenue rise by an impressive 103% in the third quarter, Jaluria argued that this level of growth is unsustainable. He noted that Palantir's commercial business has benefited from its strategy of investing in newly public companies in exchange for them agreeing to use its software. Jaluria believes these investments will have less of an impact over time.</p><p><blockquote>此外，尽管Palantir第三季度美国商业收入增长了令人印象深刻的103%，但Jaluria认为这种增长水平是不可持续的。他指出，Palantir的商业业务受益于其投资新上市公司以换取它们同意使用其软件的策略。Jaluria认为，随着时间的推移，这些投资的影响会越来越小。</blockquote></p><p> For these reasons, Jaluria is now less confident that Palantir can achieve its revenue growth target of at least 30% annually through 2025.</p><p><blockquote>出于这些原因，Jaluria现在对Palantir能否实现到2025年每年至少30%的收入增长目标信心不足。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> As a premium-priced growth stock, Palantir is highly exposed to anything that would make investors question whether it can reach its long-term expansion goals. Even after today's stock price decline, Palantir's shares trade for more than 100 times its projected earnings in 2022. Thus, should more analysts raise concerns about its growth projections, Palantir's share price could have further to fall.</p><p><blockquote>作为一只溢价成长型股票，Palantir很容易受到任何会让投资者质疑其能否实现长期扩张目标的影响。即使在今天的股价下跌之后，Palantir的股价仍是其2022年预计收益的100多倍。因此，如果更多分析师对其增长预测表示担忧，Palantir的股价可能会进一步下跌。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/11/10/why-palantir-stock-dropped-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.fool.com/investing/2021/11/10/why-palantir-stock-dropped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101863758","content_text":"What happened\nShares of Palantir Technologies fell 7% on Wednesday, following bearish analyst commentary.\nSo what\nPalantir's revenue climbed 36% year over year to $392 million in the third quarter. That marked a notable deceleration from the 49% growth the data software provider delivered in the second quarter.\nThe slowdown was enough for RBC Capital analyst Rishi Jaluria to cut his rating on Palantir's stock from sector perform to underperform and slash his share price forecast from $25 to $19.\nJaluria was particularly concerned with the decline in Palantir's revenue growth rate in its core government business, which fell to 34% from 66% in the second quarter. \"We believe Palantir got direct benefits from COVID-related spending and those benefits have already faded,\" Jaluria said.\nMoreover, although Palantir saw its U.S. commercial revenue rise by an impressive 103% in the third quarter, Jaluria argued that this level of growth is unsustainable. He noted that Palantir's commercial business has benefited from its strategy of investing in newly public companies in exchange for them agreeing to use its software. Jaluria believes these investments will have less of an impact over time.\nFor these reasons, Jaluria is now less confident that Palantir can achieve its revenue growth target of at least 30% annually through 2025.\nNow what\nAs a premium-priced growth stock, Palantir is highly exposed to anything that would make investors question whether it can reach its long-term expansion goals. Even after today's stock price decline, Palantir's shares trade for more than 100 times its projected earnings in 2022. Thus, should more analysts raise concerns about its growth projections, Palantir's share price could have further to fall.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":945,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845445718,"gmtCreate":1636363763203,"gmtModify":1636364027631,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Steady","listText":"Steady","text":"Steady","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845445718","repostId":"1107472736","repostType":4,"repost":{"id":"1107472736","kind":"news","pubTimestamp":1636357314,"share":"https://www.laohu8.com/m/news/1107472736?lang=zh_CN&edition=full","pubTime":"2021-11-08 15:41","market":"us","language":"en","title":"Buffett’s Berkshire Appetite Surpasses Cash Spent on Apple Stock<blockquote>巴菲特对Berkshire的兴趣超过了在苹果股票上花费的现金</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107472736","media":"Bloomberg","summary":"(Bloomberg) -- Warren Buffett has spent more money buying back Berkshire Hathaway Inc.’s stock in re","content":"<p>(Bloomberg) -- Warren Buffett has spent more money buying back Berkshire Hathaway Inc.’s stock in recent years than he did amassing his biggest equity bet on Apple Inc.</p><p><blockquote>最近几年，巴菲特花在回购伯克希尔哈撒韦公司股票上的钱超过了他在苹果公司的最大股票赌注。</blockquote></p><p> Berkshire spent nearly $20 billion more repurchasing its own stock since the middle of 2018 than it deployed accumulating its Apple stake through the end of last year. In total, Buffett poured about $51 billion into buybacks since a change to its policy more than three years ago, and appears to have continued snapping up at least $1.7 billion of stock since the end of September.</p><p><blockquote>自2018年年中以来，伯克希尔回购自己股票的支出比截至去年底积累苹果股份的支出多了近200亿美元。自三年多前改变政策以来，巴菲特总共投入了约510亿美元用于回购，并且自9月底以来似乎继续抢购至少17亿美元的股票。</blockquote></p><p> Buffett, Berkshire’s chairman and chief executive officer, has built Berkshire into a sprawling conglomerate valued at more than $650 billion, but that immense size has heaped pressure on his need for what he deemed an “elephant-sized” acquisition to ramp up Berkshire’s growth. Buffett has been foiled on his recent deal hunt, outbid at times by aggressive private equity firms. That’s left him increasingly relying on buybacks, with more than $20 billion of repurchases so far this year, as a way to put some of Berkshire’s record cash pile to work.</p><p><blockquote>伯克希尔董事长兼首席执行官巴菲特将伯克希尔打造成为一家估值超过6500亿美元的庞大企业集团，但巨大的规模给他带来了压力，他需要进行一次他认为是“大象规模”的收购来促进伯克希尔的增长。巴菲特在最近的交易中遭遇挫折，有时被激进的私募股权公司出价高于。这使得他越来越依赖回购，今年迄今为止已回购超过200亿美元，以此作为让伯克希尔创纪录的现金储备发挥作用的一种方式。</blockquote></p><p> “The bull case would say they bought back $20 billion worth of their stock because they’re confident in their future outlook and that should be a catalyst for the stock, and my sense is it probably will,” Cathy Seifert, an analyst at CFRA Research, said. “The bear case, which is also relevant to point out, is this is a company that has had, as a stated desire, the need to make additional acquisitions and they haven’t been able to do that.”</p><p><blockquote>CFRA分析师凯茜·塞弗特(Cathy Seifert)表示：“牛市的情况是，他们回购了价值200亿美元的股票，因为他们对未来前景充满信心，这应该会成为该股的催化剂，我的感觉是很可能会。”研究，说。“同样需要指出的看跌案例是，这家公司有明确的愿望，需要进行额外的收购，但他们未能做到这一点。”</blockquote></p><p> It’s a marked shift for a CEO who previously shunned buybacks. For years, Buffett preferred large deals and spending money snapping up other company’s stocks over repurchasing Berkshire’s own shares. But that changed in 2018 when the company’s board lifted a cap on buybacks, giving Buffett and his longtime business partner, Charlie Munger, more flexibility to parcel out profits.</p><p><blockquote>对于之前回避回购的首席执行官来说，这是一个显着的转变。多年来，巴菲特更喜欢大宗交易和花钱抢购其他公司的股票，而不是回购伯克希尔自己的股票。但这种情况在2018年发生了变化，当时公司董事会取消了回购上限，让巴菲特和他的长期商业伙伴查理·芒格在分配利润方面有了更大的灵活性。</blockquote></p><p> Buybacks have now surpassed even Berkshire’s largest holding, an Apple Inc. stake valued at more than $121 billion at the end of September. The company has spent just $31 billion buying Apple shares since it began accumulating that stake in 2016 through the end of 2020, according to the most recent data available.</p><p><blockquote>目前，伯克希尔哈撒韦的回购规模甚至超过了伯克希尔哈撒韦最大的持股——截至9月底，伯克希尔哈撒韦公司持有的苹果股份价值超过1210亿美元。根据最新数据，自2016年开始增持苹果股票到2020年底，该公司仅花费了310亿美元购买该股票。</blockquote></p><p> What Bloomberg Intelligence Says</p><p><blockquote>彭博资讯怎么说</blockquote></p><p> “We believe Warren Buffett’s significant share repurchases show his conservatism as rising valuations make deals he may find attractive more scarce.”</p><p><blockquote>“我们认为，沃伦·巴菲特的大规模股票回购显示了他的保守主义，因为估值上升使他可能认为有吸引力的交易变得更加稀缺。”</blockquote></p><p> -- Matthew Palazola and Kylie Towbin, BI analysts</p><p><blockquote>——BI分析师Matthew Palazola和Kylie Towbin</blockquote></p><p> All the buyback activity, while significant in size, hasn’t been enough to meaningfully whittle away some of the conglomerate’s cash. Berkshire ended September with a record $149.2 billion of funds in its coffers. While investors often want management to remain disciplined on when and how it spends the money, the swelling cash pile is “somewhat disappointing,” according to Edward Jones analyst Jim Shanahan.</p><p><blockquote>所有的回购活动虽然规模很大，但还不足以有意义地减少该集团的部分现金。截至9月底，伯克希尔的金库资金达到创纪录的1,492亿美元。爱德华·琼斯(Edward Jones)分析师吉姆·沙纳汉(Jim Shanahan)表示，虽然投资者通常希望管理层在何时以及如何花钱方面保持纪律，但不断膨胀的现金储备“有些令人失望”。</blockquote></p><p> “Buybacks were fine, but cash balances increased again,” Shanahan said. “Cash is now approaching $150 billion. That certainly was unexpected earlier this calendar year, I would have thought they would have been able to manage that lower with a combination of investments, acquisitions and buybacks.”</p><p><blockquote>“回购很好，但现金余额再次增加，”沙纳汉说。“现金现在接近1500亿美元。这在今年早些时候肯定是出乎意料的，我本以为他们能够通过投资、收购和回购的结合来控制更低的水平。”</blockquote></p><p> The Omaha, Nebraska-based business, which reported third-quarter earnings Saturday, posted an 18% gain in operating profit during that period, buoyed by record railroad earnings and strong results from its energy businesses. That helped offset even more underwriting losses at its group of insurers, which have been hit by catastrophes such as Hurricane Ida and more frequent claims from its drivers at auto insurer Geico.</p><p><blockquote>这家总部位于内布拉斯加州奥马哈的公司周六公布了第三季度收益，在创纪录的铁路收益和能源业务强劲业绩的推动下，同期营业利润增长了18%。这有助于抵消其保险公司集团更多的承保损失，这些保险公司受到了飓风艾达等灾难的打击，以及汽车保险公司Geico司机更频繁的索赔。</blockquote></p><p> Berkshire also disclosed that it bought back at least $1.7 billion in stock from the end of September through October 27, according to Saturday’s filing. Empire Financial Research’s Whitney Tilson, who’s attended the Berkshire annual meeting for more than two decades, applauded the buyback, but noted that he’d still prefer to see Buffett find the next lucrative stock bet.</p><p><blockquote>根据周六提交的文件，伯克希尔还透露，从9月底到10月27日，该公司回购了至少17亿美元的股票。帝国金融研究公司(Empire Financial Research)的惠特尼·蒂尔森(Whitney Tilson)二十多年来一直参加伯克希尔年会，他对此次回购表示赞赏，但指出他仍然希望看到巴菲特找到下一个利润丰厚的股票押注。</blockquote></p><p> “If Buffett could find another Apple, clearly I’d rather have him allocate to that,” Tilson said. “Buying back Berkshire stock makes sense when you’re drowning in cash.”</p><p><blockquote>蒂尔森说：“如果巴菲特能找到另一家苹果，显然我宁愿让巴菲特投资。”“当你被现金淹没时，回购伯克希尔股票是有意义的。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett’s Berkshire Appetite Surpasses Cash Spent on Apple Stock<blockquote>巴菲特对Berkshire的兴趣超过了在苹果股票上花费的现金</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett’s Berkshire Appetite Surpasses Cash Spent on Apple Stock<blockquote>巴菲特对Berkshire的兴趣超过了在苹果股票上花费的现金</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-08 15:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Warren Buffett has spent more money buying back Berkshire Hathaway Inc.’s stock in recent years than he did amassing his biggest equity bet on Apple Inc.</p><p><blockquote>最近几年，巴菲特花在回购伯克希尔哈撒韦公司股票上的钱超过了他在苹果公司的最大股票赌注。</blockquote></p><p> Berkshire spent nearly $20 billion more repurchasing its own stock since the middle of 2018 than it deployed accumulating its Apple stake through the end of last year. In total, Buffett poured about $51 billion into buybacks since a change to its policy more than three years ago, and appears to have continued snapping up at least $1.7 billion of stock since the end of September.</p><p><blockquote>自2018年年中以来，伯克希尔回购自己股票的支出比截至去年底积累苹果股份的支出多了近200亿美元。自三年多前改变政策以来，巴菲特总共投入了约510亿美元用于回购，并且自9月底以来似乎继续抢购至少17亿美元的股票。</blockquote></p><p> Buffett, Berkshire’s chairman and chief executive officer, has built Berkshire into a sprawling conglomerate valued at more than $650 billion, but that immense size has heaped pressure on his need for what he deemed an “elephant-sized” acquisition to ramp up Berkshire’s growth. Buffett has been foiled on his recent deal hunt, outbid at times by aggressive private equity firms. That’s left him increasingly relying on buybacks, with more than $20 billion of repurchases so far this year, as a way to put some of Berkshire’s record cash pile to work.</p><p><blockquote>伯克希尔董事长兼首席执行官巴菲特将伯克希尔打造成为一家估值超过6500亿美元的庞大企业集团，但巨大的规模给他带来了压力，他需要进行一次他认为是“大象规模”的收购来促进伯克希尔的增长。巴菲特在最近的交易中遭遇挫折，有时被激进的私募股权公司出价高于。这使得他越来越依赖回购，今年迄今为止已回购超过200亿美元，以此作为让伯克希尔创纪录的现金储备发挥作用的一种方式。</blockquote></p><p> “The bull case would say they bought back $20 billion worth of their stock because they’re confident in their future outlook and that should be a catalyst for the stock, and my sense is it probably will,” Cathy Seifert, an analyst at CFRA Research, said. “The bear case, which is also relevant to point out, is this is a company that has had, as a stated desire, the need to make additional acquisitions and they haven’t been able to do that.”</p><p><blockquote>CFRA分析师凯茜·塞弗特(Cathy Seifert)表示：“牛市的情况是，他们回购了价值200亿美元的股票，因为他们对未来前景充满信心，这应该会成为该股的催化剂，我的感觉是很可能会。”研究，说。“同样需要指出的看跌案例是，这家公司有明确的愿望，需要进行额外的收购，但他们未能做到这一点。”</blockquote></p><p> It’s a marked shift for a CEO who previously shunned buybacks. For years, Buffett preferred large deals and spending money snapping up other company’s stocks over repurchasing Berkshire’s own shares. But that changed in 2018 when the company’s board lifted a cap on buybacks, giving Buffett and his longtime business partner, Charlie Munger, more flexibility to parcel out profits.</p><p><blockquote>对于之前回避回购的首席执行官来说，这是一个显着的转变。多年来，巴菲特更喜欢大宗交易和花钱抢购其他公司的股票，而不是回购伯克希尔自己的股票。但这种情况在2018年发生了变化，当时公司董事会取消了回购上限，让巴菲特和他的长期商业伙伴查理·芒格在分配利润方面有了更大的灵活性。</blockquote></p><p> Buybacks have now surpassed even Berkshire’s largest holding, an Apple Inc. stake valued at more than $121 billion at the end of September. The company has spent just $31 billion buying Apple shares since it began accumulating that stake in 2016 through the end of 2020, according to the most recent data available.</p><p><blockquote>目前，伯克希尔哈撒韦的回购规模甚至超过了伯克希尔哈撒韦最大的持股——截至9月底，伯克希尔哈撒韦公司持有的苹果股份价值超过1210亿美元。根据最新数据，自2016年开始增持苹果股票到2020年底，该公司仅花费了310亿美元购买该股票。</blockquote></p><p> What Bloomberg Intelligence Says</p><p><blockquote>彭博资讯怎么说</blockquote></p><p> “We believe Warren Buffett’s significant share repurchases show his conservatism as rising valuations make deals he may find attractive more scarce.”</p><p><blockquote>“我们认为，沃伦·巴菲特的大规模股票回购显示了他的保守主义，因为估值上升使他可能认为有吸引力的交易变得更加稀缺。”</blockquote></p><p> -- Matthew Palazola and Kylie Towbin, BI analysts</p><p><blockquote>——BI分析师Matthew Palazola和Kylie Towbin</blockquote></p><p> All the buyback activity, while significant in size, hasn’t been enough to meaningfully whittle away some of the conglomerate’s cash. Berkshire ended September with a record $149.2 billion of funds in its coffers. While investors often want management to remain disciplined on when and how it spends the money, the swelling cash pile is “somewhat disappointing,” according to Edward Jones analyst Jim Shanahan.</p><p><blockquote>所有的回购活动虽然规模很大，但还不足以有意义地减少该集团的部分现金。截至9月底，伯克希尔的金库资金达到创纪录的1,492亿美元。爱德华·琼斯(Edward Jones)分析师吉姆·沙纳汉(Jim Shanahan)表示，虽然投资者通常希望管理层在何时以及如何花钱方面保持纪律，但不断膨胀的现金储备“有些令人失望”。</blockquote></p><p> “Buybacks were fine, but cash balances increased again,” Shanahan said. “Cash is now approaching $150 billion. That certainly was unexpected earlier this calendar year, I would have thought they would have been able to manage that lower with a combination of investments, acquisitions and buybacks.”</p><p><blockquote>“回购很好，但现金余额再次增加，”沙纳汉说。“现金现在接近1500亿美元。这在今年早些时候肯定是出乎意料的，我本以为他们能够通过投资、收购和回购的结合来控制更低的水平。”</blockquote></p><p> The Omaha, Nebraska-based business, which reported third-quarter earnings Saturday, posted an 18% gain in operating profit during that period, buoyed by record railroad earnings and strong results from its energy businesses. That helped offset even more underwriting losses at its group of insurers, which have been hit by catastrophes such as Hurricane Ida and more frequent claims from its drivers at auto insurer Geico.</p><p><blockquote>这家总部位于内布拉斯加州奥马哈的公司周六公布了第三季度收益，在创纪录的铁路收益和能源业务强劲业绩的推动下，同期营业利润增长了18%。这有助于抵消其保险公司集团更多的承保损失，这些保险公司受到了飓风艾达等灾难的打击，以及汽车保险公司Geico司机更频繁的索赔。</blockquote></p><p> Berkshire also disclosed that it bought back at least $1.7 billion in stock from the end of September through October 27, according to Saturday’s filing. Empire Financial Research’s Whitney Tilson, who’s attended the Berkshire annual meeting for more than two decades, applauded the buyback, but noted that he’d still prefer to see Buffett find the next lucrative stock bet.</p><p><blockquote>根据周六提交的文件，伯克希尔还透露，从9月底到10月27日，该公司回购了至少17亿美元的股票。帝国金融研究公司(Empire Financial Research)的惠特尼·蒂尔森(Whitney Tilson)二十多年来一直参加伯克希尔年会，他对此次回购表示赞赏，但指出他仍然希望看到巴菲特找到下一个利润丰厚的股票押注。</blockquote></p><p> “If Buffett could find another Apple, clearly I’d rather have him allocate to that,” Tilson said. “Buying back Berkshire stock makes sense when you’re drowning in cash.”</p><p><blockquote>蒂尔森说：“如果巴菲特能找到另一家苹果，显然我宁愿让巴菲特投资。”“当你被现金淹没时，回购伯克希尔股票是有意义的。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/buffett-berkshire-appetite-surpasses-cash-173252893.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://finance.yahoo.com/news/buffett-berkshire-appetite-surpasses-cash-173252893.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107472736","content_text":"(Bloomberg) -- Warren Buffett has spent more money buying back Berkshire Hathaway Inc.’s stock in recent years than he did amassing his biggest equity bet on Apple Inc.\nBerkshire spent nearly $20 billion more repurchasing its own stock since the middle of 2018 than it deployed accumulating its Apple stake through the end of last year. In total, Buffett poured about $51 billion into buybacks since a change to its policy more than three years ago, and appears to have continued snapping up at least $1.7 billion of stock since the end of September.\nBuffett, Berkshire’s chairman and chief executive officer, has built Berkshire into a sprawling conglomerate valued at more than $650 billion, but that immense size has heaped pressure on his need for what he deemed an “elephant-sized” acquisition to ramp up Berkshire’s growth. Buffett has been foiled on his recent deal hunt, outbid at times by aggressive private equity firms. That’s left him increasingly relying on buybacks, with more than $20 billion of repurchases so far this year, as a way to put some of Berkshire’s record cash pile to work.\n“The bull case would say they bought back $20 billion worth of their stock because they’re confident in their future outlook and that should be a catalyst for the stock, and my sense is it probably will,” Cathy Seifert, an analyst at CFRA Research, said. “The bear case, which is also relevant to point out, is this is a company that has had, as a stated desire, the need to make additional acquisitions and they haven’t been able to do that.”\nIt’s a marked shift for a CEO who previously shunned buybacks. For years, Buffett preferred large deals and spending money snapping up other company’s stocks over repurchasing Berkshire’s own shares. But that changed in 2018 when the company’s board lifted a cap on buybacks, giving Buffett and his longtime business partner, Charlie Munger, more flexibility to parcel out profits.\nBuybacks have now surpassed even Berkshire’s largest holding, an Apple Inc. stake valued at more than $121 billion at the end of September. The company has spent just $31 billion buying Apple shares since it began accumulating that stake in 2016 through the end of 2020, according to the most recent data available.\nWhat Bloomberg Intelligence Says\n“We believe Warren Buffett’s significant share repurchases show his conservatism as rising valuations make deals he may find attractive more scarce.”\n-- Matthew Palazola and Kylie Towbin, BI analysts\nAll the buyback activity, while significant in size, hasn’t been enough to meaningfully whittle away some of the conglomerate’s cash. Berkshire ended September with a record $149.2 billion of funds in its coffers. While investors often want management to remain disciplined on when and how it spends the money, the swelling cash pile is “somewhat disappointing,” according to Edward Jones analyst Jim Shanahan.\n“Buybacks were fine, but cash balances increased again,” Shanahan said. “Cash is now approaching $150 billion. That certainly was unexpected earlier this calendar year, I would have thought they would have been able to manage that lower with a combination of investments, acquisitions and buybacks.”\nThe Omaha, Nebraska-based business, which reported third-quarter earnings Saturday, posted an 18% gain in operating profit during that period, buoyed by record railroad earnings and strong results from its energy businesses. That helped offset even more underwriting losses at its group of insurers, which have been hit by catastrophes such as Hurricane Ida and more frequent claims from its drivers at auto insurer Geico.\nBerkshire also disclosed that it bought back at least $1.7 billion in stock from the end of September through October 27, according to Saturday’s filing. Empire Financial Research’s Whitney Tilson, who’s attended the Berkshire annual meeting for more than two decades, applauded the buyback, but noted that he’d still prefer to see Buffett find the next lucrative stock bet.\n“If Buffett could find another Apple, clearly I’d rather have him allocate to that,” Tilson said. “Buying back Berkshire stock makes sense when you’re drowning in cash.”","news_type":1,"symbols_score_info":{"BRK.A":0.9,"BRK.B":0.9}},"isVote":1,"tweetType":1,"viewCount":546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845170146,"gmtCreate":1636324728235,"gmtModify":1636324728647,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Emmm....","listText":"Emmm....","text":"Emmm....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845170146","repostId":"2180739446","repostType":2,"isVote":1,"tweetType":1,"viewCount":1035,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840590596,"gmtCreate":1635655465025,"gmtModify":1635655465179,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Alright!","listText":"Alright!","text":"Alright!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840590596","repostId":"1104228860","repostType":4,"isVote":1,"tweetType":1,"viewCount":1040,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852531319,"gmtCreate":1635290310555,"gmtModify":1635290313001,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Looking forward","listText":"Looking forward","text":"Looking forward","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852531319","repostId":"2175611011","repostType":2,"isVote":1,"tweetType":1,"viewCount":1383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856560044,"gmtCreate":1635203228838,"gmtModify":1635203229283,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856560044","repostId":"2178467422","repostType":4,"isVote":1,"tweetType":1,"viewCount":637,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856582067,"gmtCreate":1635202994894,"gmtModify":1635203006689,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Shall see","listText":"Shall see","text":"Shall see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856582067","repostId":"2178276504","repostType":4,"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856589039,"gmtCreate":1635202795662,"gmtModify":1635202796059,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Looking forward","listText":"Looking forward","text":"Looking forward","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856589039","repostId":"1163628063","repostType":4,"isVote":1,"tweetType":1,"viewCount":744,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856166008,"gmtCreate":1635161868226,"gmtModify":1635161868657,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Let's go!!!","listText":"Let's go!!!","text":"Let's go!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856166008","repostId":"1158353877","repostType":4,"repost":{"id":"1158353877","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635161224,"share":"https://www.laohu8.com/m/news/1158353877?lang=zh_CN&edition=full","pubTime":"2021-10-25 19:27","market":"us","language":"en","title":"Tesla shares rose more than 4% in premarket trading.<blockquote>特斯拉股价在盘前交易中上涨超过4%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158353877","media":"Tiger Newspress","summary":"Tesla shares rose more than 4% in premarket trading.\nHertz Global Holdings Inc., barely four months ","content":"<p>Tesla&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>特斯拉股价在盘前交易中上涨超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7c0ce6b1c030f3cb1213aa47ad4646f3\" tg-width=\"884\" tg-height=\"607\" referrerpolicy=\"no-referrer\">Hertz Global Holdings Inc., barely four months out of bankruptcy, placed an order for 100,000 Teslas in the first step of an ambitious plan to electrify its rental-car fleet, according to people with knowledge of the matter, Bloomberg News reports.</p><p><blockquote>据彭博新闻报道，据知情人士透露，破产仅四个月的赫兹全球控股公司（Hertz Global Holdings Inc.）订购了10万辆特斯拉，这是其租赁车队电气化雄心勃勃计划的第一步。</blockquote></p><p> It’s the single-largest purchase ever for electric vehicles and represents about $4.2 billion of revenue forTesla Inc., according to the people, who asked not to be identified because the information is private.</p><p><blockquote>据知情人士透露，这是有史以来最大的电动汽车单笔采购，为特斯拉公司带来了约42亿美元的收入。由于信息是私人的，这些人士要求匿名。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares rose more than 4% in premarket trading.<blockquote>特斯拉股价在盘前交易中上涨超过4%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares rose more than 4% in premarket trading.<blockquote>特斯拉股价在盘前交易中上涨超过4%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-25 19:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;premarket&nbsp;trading.</p><p><blockquote>特斯拉股价在盘前交易中上涨超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7c0ce6b1c030f3cb1213aa47ad4646f3\" tg-width=\"884\" tg-height=\"607\" referrerpolicy=\"no-referrer\">Hertz Global Holdings Inc., barely four months out of bankruptcy, placed an order for 100,000 Teslas in the first step of an ambitious plan to electrify its rental-car fleet, according to people with knowledge of the matter, Bloomberg News reports.</p><p><blockquote>据彭博新闻报道，据知情人士透露，破产仅四个月的赫兹全球控股公司（Hertz Global Holdings Inc.）订购了10万辆特斯拉，这是其租赁车队电气化雄心勃勃计划的第一步。</blockquote></p><p> It’s the single-largest purchase ever for electric vehicles and represents about $4.2 billion of revenue forTesla Inc., according to the people, who asked not to be identified because the information is private.</p><p><blockquote>据知情人士透露，这是有史以来最大的电动汽车单笔采购，为特斯拉公司带来了约42亿美元的收入。由于信息是私人的，这些人士要求匿名。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158353877","content_text":"Tesla shares rose more than 4% in premarket trading.\nHertz Global Holdings Inc., barely four months out of bankruptcy, placed an order for 100,000 Teslas in the first step of an ambitious plan to electrify its rental-car fleet, according to people with knowledge of the matter, Bloomberg News reports.\nIt’s the single-largest purchase ever for electric vehicles and represents about $4.2 billion of revenue forTesla Inc., according to the people, who asked not to be identified because the information is private.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856161756,"gmtCreate":1635161823019,"gmtModify":1635161823409,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579743164156658","idStr":"3579743164156658"},"themes":[],"htmlText":"Steady","listText":"Steady","text":"Steady","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856161756","repostId":"2178808449","repostType":4,"isVote":1,"tweetType":1,"viewCount":683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":898003947,"gmtCreate":1628437909789,"gmtModify":1633747142728,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/898003947","repostId":"1180529438","repostType":4,"repost":{"id":"1180529438","kind":"news","pubTimestamp":1628386129,"share":"https://www.laohu8.com/m/news/1180529438?lang=zh_CN&edition=full","pubTime":"2021-08-08 09:28","market":"us","language":"en","title":"SEC Moves First DeFi Unregistered Securities Lawsuit<blockquote>SEC提起首起DeFi未注册证券诉讼</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180529438","media":"Benzinga","summary":"The United States Securities and Exchange Commission  sued the organization responsible for the development of a decentralized finance  protocol over activities involved with the project for the first time.What Happened: According to a Friday SEC announcement, the agency has sued Cayman Islands-based Blockchain Credit Partners and two of its top executives over allegedly selling unregistered securities through its DeFi Money Market platform from February 2020 to February 2021. The firm purported","content":"<p><div> The United States Securities and Exchange Commission (SEC) sued the organization responsible for the development of a decentralized finance (DeFi) protocol over activities involved with the project ...</p><p><blockquote><div>美国证券交易委员会（SEC）就该项目涉及的活动起诉了负责开发分散金融（DeFi）协议的组织...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SEC Moves First DeFi Unregistered Securities Lawsuit<blockquote>SEC提起首起DeFi未注册证券诉讼</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSEC Moves First DeFi Unregistered Securities Lawsuit<blockquote>SEC提起首起DeFi未注册证券诉讼</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-08-08 09:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The United States Securities and Exchange Commission (SEC) sued the organization responsible for the development of a decentralized finance (DeFi) protocol over activities involved with the project ...</p><p><blockquote><div>美国证券交易委员会（SEC）就该项目涉及的活动起诉了负责开发分散金融（DeFi）协议的组织...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc."},"source_url":"https://www.benzinga.com/markets/cryptocurrency/21/08/22378359/sec-moves-first-defi-unregistered-securities-lawsuit","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180529438","content_text":"The United States Securities and Exchange Commission (SEC) sued the organization responsible for the development of a decentralized finance (DeFi) protocol over activities involved with the project for the first time.\nWhat Happened: According to a Friday SEC announcement, the agency has sued Cayman Islands-based Blockchain Credit Partners and two of its top executives over allegedly selling unregistered securities through its DeFi Money Market platform from February 2020 to February 2021. The firm purportedly sold over $30 million worth of two types of tokens that the SEC deemed to be securities that should have been registered as such.\nThe SEC notes that Blockchain Credit Partners founders Gregory Keough and Derek Acree will have to pay fines of $125,000 while the company itself also agreed to pay $12.8 million in disgorgement. The settlement does not indicate an admition or denial the accusations.\nNew Game, Old Rules?\nSEC Enforcement Director Gurbir Grewal explained that \"full and honest disclosure remains the cornerstone of our securities laws — no matter what technologies are used to offer and sell those securities.\" This comment makes it very clear that slapping the DeFi label on a project and hoping to avoid regulation this way works no better than calling it a \"utility token\" prevented falling under the SEC's scrutiny during 2017's initial coin offering craze.\nThe SEC is trying to send the clear rule that the new kind of financial organizations that operate on blockchains have to still play by the old rules that govern traditional finance. At the same time, market onlookers are not sure if the regulator is actually right.\nIn a way, it is a tour de force where the regulator wins every time it has a way to take enforcement action, but these new organizations potentially have a very real way to make enforcement impossible — or at the very least impractical. The only protection against enforcement by the SEC and other regulators is decentralization and the only reason why the SEC was able to act in this case is that a centralized organization such as Blockchain Credit Partners exists.\nWhat's Next:If no company exists and all that there is to a DeFi protocol is a set of smart contracts deployed on a blockchain by a group of anonymous developers scattered around the world there is very little that the SEC can do short of attacking the blockchain itself. This is where the decentralization of the underlying blockchain comes into play: will the regulators for instance be able to force Ethereum's (CRYPTO: ETH) core development team to write an update stopping such a project?\nIf the regulators would actually be able to force the blockchain's developers to write such an update, would node operators and miners or stakers adopt this software or would they refuse to? Such situations will be the real test of the decentralization and reliability of any blockchain that many are waiting to happen. Regulators are seeing power slipping away between their fingers like sand, and they are going to try to grab it.","news_type":1,"symbols_score_info":{"COIN":0.9}},"isVote":1,"tweetType":1,"viewCount":561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884623528,"gmtCreate":1631888101964,"gmtModify":1632805555276,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/884623528","repostId":"2168002520","repostType":4,"isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161515051,"gmtCreate":1623934569073,"gmtModify":1634025695477,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment. Thanks !","listText":"Please like and comment. Thanks !","text":"Please like and comment. Thanks !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/161515051","repostId":"1121317952","repostType":4,"repost":{"id":"1121317952","kind":"news","pubTimestamp":1623934346,"share":"https://www.laohu8.com/m/news/1121317952?lang=zh_CN&edition=full","pubTime":"2021-06-17 20:52","market":"us","language":"en","title":"Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal<blockquote>高盛支持的SPAC将以26亿美元的交易让Mirion Tech上市</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1121317952","media":"Reuters","summary":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity  of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.PIPE als","content":"<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.</p><p><blockquote>-辐射检测提供商Mirion Technologies Inc周四表示，将通过与高盛集团支持的特殊目的收购公司合并上市，该交易对合并后实体的估值为26亿美元。</blockquote></p><p> The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management &amp; Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.</p><p><blockquote>与GS Acquisition Holdings Corp II的交易将得到富达管理与研究公司有限责任公司、贝莱德、路博迈基金和骏利亨德森投资者等投资者9亿美元的公共股权私人投资(PIPE)的支持。</blockquote></p><p> PIPE also includes a $200 million investment from Goldman Sachs.</p><p><blockquote>PIPE还包括高盛的2亿美元投资。</blockquote></p><p> Mirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.</p><p><blockquote>据彭博社报道，Mirion归总部位于伦敦的私募股权公司Charterhouse Capital Partners所有，该公司在2019年停止了之前的尝试后，于今年早些时候恢复了该公司的出售。</blockquote></p><p> Charterhouse bought Mirion in 2015 for $750 million.</p><p><blockquote>Charterhouse于2015年以7.5亿美元收购了Mirion。</blockquote></p><p> Mirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.</p><p><blockquote>Mirion进行了一系列收购，以扩大其服务范围，包括核、国防和医疗终端市场的检测、测量和分析解决方案。其最近的收购包括总部位于德国的Dosimetrics GmbH和Sun Nuclear Corp。</blockquote></p><p> GS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.</p><p><blockquote>GS Acquisition是一家特殊目的收购公司（SPAC），去年6月以7亿美元的IPO上市。</blockquote></p><p> SPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p><blockquote>SPAC是空壳公司，通过首次公开募股筹集资金，以便在以后通过合并使私营公司上市。</blockquote></p><p> Concerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.</p><p><blockquote>最近几周，人们担心SPAC以非常高的估值让尚未盈利、亏损的电动汽车制造商上市，这让PIPE投资者望而却步。</blockquote></p><p> Mirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.</p><p><blockquote>交易于今年下半年完成后，Mirion将在纽约证券交易所上市，股票代码为“MIR”。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal<blockquote>高盛支持的SPAC将以26亿美元的交易让Mirion Tech上市</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman-backed SPAC to take Mirion Tech public in $2.6 billion deal<blockquote>高盛支持的SPAC将以26亿美元的交易让Mirion Tech上市</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-06-17 20:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.</p><p><blockquote>-辐射检测提供商Mirion Technologies Inc周四表示，将通过与高盛集团支持的特殊目的收购公司合并上市，该交易对合并后实体的估值为26亿美元。</blockquote></p><p> The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management &amp; Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.</p><p><blockquote>与GS Acquisition Holdings Corp II的交易将得到富达管理与研究公司有限责任公司、贝莱德、路博迈基金和骏利亨德森投资者等投资者9亿美元的公共股权私人投资(PIPE)的支持。</blockquote></p><p> PIPE also includes a $200 million investment from Goldman Sachs.</p><p><blockquote>PIPE还包括高盛的2亿美元投资。</blockquote></p><p> Mirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.</p><p><blockquote>据彭博社报道，Mirion归总部位于伦敦的私募股权公司Charterhouse Capital Partners所有，该公司在2019年停止了之前的尝试后，于今年早些时候恢复了该公司的出售。</blockquote></p><p> Charterhouse bought Mirion in 2015 for $750 million.</p><p><blockquote>Charterhouse于2015年以7.5亿美元收购了Mirion。</blockquote></p><p> Mirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.</p><p><blockquote>Mirion进行了一系列收购，以扩大其服务范围，包括核、国防和医疗终端市场的检测、测量和分析解决方案。其最近的收购包括总部位于德国的Dosimetrics GmbH和Sun Nuclear Corp。</blockquote></p><p> GS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.</p><p><blockquote>GS Acquisition是一家特殊目的收购公司（SPAC），去年6月以7亿美元的IPO上市。</blockquote></p><p> SPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.</p><p><blockquote>SPAC是空壳公司，通过首次公开募股筹集资金，以便在以后通过合并使私营公司上市。</blockquote></p><p> Concerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.</p><p><blockquote>最近几周，人们担心SPAC以非常高的估值让尚未盈利、亏损的电动汽车制造商上市，这让PIPE投资者望而却步。</blockquote></p><p> Mirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.</p><p><blockquote>交易于今年下半年完成后，Mirion将在纽约证券交易所上市，股票代码为“MIR”。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSAH.U":"GS Acquisition Holdings Corp II"},"source_url":"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121317952","content_text":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.\nThe deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.\nPIPE also includes a $200 million investment from Goldman Sachs.\nMirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.\nCharterhouse bought Mirion in 2015 for $750 million.\nMirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.\nGS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.\nSPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.\nConcerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.\nMirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.","news_type":1,"symbols_score_info":{"GSAH.U":0.9}},"isVote":1,"tweetType":1,"viewCount":537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":867964587,"gmtCreate":1633188872595,"gmtModify":1633188872947,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Comment and like please.&nbsp; Thanks&nbsp;","listText":"Comment and like please.&nbsp; Thanks&nbsp;","text":"Comment and like please. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/867964587","repostId":"1134305481","repostType":4,"repost":{"id":"1134305481","kind":"news","pubTimestamp":1633152909,"share":"https://www.laohu8.com/m/news/1134305481?lang=zh_CN&edition=full","pubTime":"2021-10-02 13:35","market":"sh","language":"en","title":"3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134305481","media":"The motley fool","summary":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this mo","content":"<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC必须在此基础上翻一番才能重温6月份的高点。查看即将上映的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart正在彻底改变消费贷款中确定信用度的方式，并且一直笑到银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，今年是动荡的一年，但自然有些投资的表现比其他投资更好。超过300只股票在2021年上涨了一倍多。如果许多获胜的投资能够在今年最后三个月保持这些收益，那将是幸运的，但那些有潜力再次翻倍的投资呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>卡骆驰</b>（纳斯达克：CROX），<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克：UPST）的价值在2021年前9个月翻了一番多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1.Crocs</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那双有洞的亮色胶鞋吗？他们大举回来了。自疫情爆发以来，Crocs的销量一直在蓬勃发展，该股也紧随其后，在2021年前9个月上涨了129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>舒适的树脂鞋在新冠肺炎危机之前就已经卷土重来，2019年的收入实现了两位数的增长，然后在2020年重复了这一壮举。动力才是真正让Crocs在2021年更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在2月份预计全年营收将增长20%至25%。下个季度的指引被上调至40%至50%之间。这种情况在今年夏天再次发生，Crocs现在的目标是2021年全年收入增长60%至65%。如果本月晚些时候公布第三季度业绩时这些目标被推得更高，您认为会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管自2019年初以来，Crocs的股价已上涨近六倍，但鉴于其加速增长，其定价合理。该公司今年市盈率为21倍，明年目标市盈率仅为17倍。显然还有增加这些市盈率的空间，华尔街终于像客户一样对Crocs作为一项投资感到满意。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商在这个名单上，但情节曲折是电影如此优秀的原因。AMC院线确实已经升值——无论是股价还是流通股数量都增长了五倍——以至于其估值相对于同行来说已经不正常了。如果您想对电影院行业的复苏进行纯粹的投资，您会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为一种流行的股票和文化现象，很难否认AMC在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢夺。今年没有一家公司的市值像AMC那样膨胀，但这也是一只进入第四季度的股票，股价仅为6月份峰值时的一半多一点。简而言之，它必须在这里翻倍才能重温历史高点——但对于2021年动量股的典型代表来说，这难道不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但最初的兴奋随着随后的周末糟糕透顶而消失。然而，这一切都与管道有关。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月的上映推迟到10月及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。该行业第四季度的表现应该比反对者想象的要强劲得多，如果AMC股价回到6月初的水平——这次基本上是盈利的——那么它将不得不在此基础上翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3.暴发户</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆成熟的行业被颠覆，这就是Upstart在贷款行业所做的事情。Upstart使用人工智能和机器学习来更好地评级评估那些通常不会获得消费贷款批准的人的风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎正在急剧减速，过去三年的增长分别放缓了89%、52%和27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长90%，但在最新报告中却飙升了1,018%。不，这不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。该股在2021年前三个季度已上涨七倍，但对于这款颠覆性喷气式飞机来说，跑道还很长。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The motley fool</strong><span class=\"h-time small\">2021-10-02 13:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC必须在此基础上翻一番才能重温6月份的高点。查看即将上映的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart正在彻底改变消费贷款中确定信用度的方式，并且一直笑到银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，今年是动荡的一年，但自然有些投资的表现比其他投资更好。超过300只股票在2021年上涨了一倍多。如果许多获胜的投资能够在今年最后三个月保持这些收益，那将是幸运的，但那些有潜力再次翻倍的投资呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>卡骆驰</b>（纳斯达克：CROX），<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克：UPST）的价值在2021年前9个月翻了一番多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1.Crocs</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那双有洞的亮色胶鞋吗？他们大举回来了。自疫情爆发以来，Crocs的销量一直在蓬勃发展，该股也紧随其后，在2021年前9个月上涨了129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>舒适的树脂鞋在新冠肺炎危机之前就已经卷土重来，2019年的收入实现了两位数的增长，然后在2020年重复了这一壮举。动力才是真正让Crocs在2021年更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在2月份预计全年营收将增长20%至25%。下个季度的指引被上调至40%至50%之间。这种情况在今年夏天再次发生，Crocs现在的目标是2021年全年收入增长60%至65%。如果本月晚些时候公布第三季度业绩时这些目标被推得更高，您认为会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管自2019年初以来，Crocs的股价已上涨近六倍，但鉴于其加速增长，其定价合理。该公司今年市盈率为21倍，明年目标市盈率仅为17倍。显然还有增加这些市盈率的空间，华尔街终于像客户一样对Crocs作为一项投资感到满意。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商在这个名单上，但情节曲折是电影如此优秀的原因。AMC院线确实已经升值——无论是股价还是流通股数量都增长了五倍——以至于其估值相对于同行来说已经不正常了。如果您想对电影院行业的复苏进行纯粹的投资，您会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为一种流行的股票和文化现象，很难否认AMC在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢夺。今年没有一家公司的市值像AMC那样膨胀，但这也是一只进入第四季度的股票，股价仅为6月份峰值时的一半多一点。简而言之，它必须在这里翻倍才能重温历史高点——但对于2021年动量股的典型代表来说，这难道不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但最初的兴奋随着随后的周末糟糕透顶而消失。然而，这一切都与管道有关。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月的上映推迟到10月及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。该行业第四季度的表现应该比反对者想象的要强劲得多，如果AMC股价回到6月初的水平——这次基本上是盈利的——那么它将不得不在此基础上翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3.暴发户</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆成熟的行业被颠覆，这就是Upstart在贷款行业所做的事情。Upstart使用人工智能和机器学习来更好地评级评估那些通常不会获得消费贷款批准的人的风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎正在急剧减速，过去三年的增长分别放缓了89%、52%和27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长90%，但在最新报告中却飙升了1,018%。不，这不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。该股在2021年前三个季度已上涨七倍，但对于这款颠覆性喷气式飞机来说，跑道还很长。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/\">The motley fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CROX":"卡骆驰","UPST":"Upstart Holdings, Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134305481","content_text":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.\nUpstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.\n\n\nIt's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?\nCrocs (NASDAQ:CROX),AMC Entertainment(NYSE:AMC), andUpstart (NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.\n1. Crocs\nRemember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.\nThe comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.\nThe year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?\nDespite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.\n2. AMC Entertainment\nYou may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.\nHowever, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?\nFundamentally speaking, the catalysts are also there.Shang-Chi and the Legend of the Ten Ringsshattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.\n3. Upstart\nI love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.\nGrowth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.\nWith Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.","news_type":1,"symbols_score_info":{"AMC":0.9,"CROX":0.9,"UPST":0.9}},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886242582,"gmtCreate":1631599857546,"gmtModify":1631890053127,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment. Thanks&nbsp;","listText":"Please like and comment. Thanks&nbsp;","text":"Please like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/886242582","repostId":"1141290411","repostType":4,"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884629074,"gmtCreate":1631888020998,"gmtModify":1632805556372,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/884629074","repostId":"1171574345","repostType":4,"isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810852348,"gmtCreate":1629965781884,"gmtModify":1633681135428,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/810852348","repostId":"1170918709","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807364718,"gmtCreate":1628001218134,"gmtModify":1633754485852,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and share","listText":"Please like and share","text":"Please like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/807364718","repostId":"1145562808","repostType":4,"repost":{"id":"1145562808","kind":"news","pubTimestamp":1628000397,"share":"https://www.laohu8.com/m/news/1145562808?lang=zh_CN&edition=full","pubTime":"2021-08-03 22:19","market":"us","language":"en","title":"Fed Could Start ‘Tapering’ Soon. Don’t Expect It to Cause Havoc for the Stock Market This Time Around.<blockquote>美联储可能很快就会开始“缩减”。不要指望这次会对股市造成严重破坏。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145562808","media":"Barron's","summary":"The Federal Reserve is poised to reduce the size of its bond-buying program, so stocks could head lo","content":"<p>The Federal Reserve is poised to reduce the size of its bond-buying program, so stocks could head lower soon. The pain may not be acute, though, because investors generally expect the Fed to do just that.</p><p><blockquote>美联储准备缩减债券购买计划的规模，因此股市可能很快就会走低。不过，痛苦可能并不严重，因为投资者普遍预计美联储会这么做。</blockquote></p><p> It was a different scenario in May 2013, when Ben Bernanke, the Fed’s chief at the time, told Congress that if economic conditions kept improving, and policy makers were confident that would continue, the bank could pare back its buying. Bond yields leapt, and the S&amp;P 500 fell 5% in a five-day stretch in an episode known&nbsp;as the Taper Tantrum.</p><p><blockquote>2013年5月的情况有所不同，当时美联储主席本·伯南克(Ben Bernanke)告诉国会，如果经济状况持续改善，并且政策制定者有信心这种情况会持续下去，美联储可能会削减购买量。债券收益率飙升，标普500在五天内下跌5%，这一事件被称为“缩减恐慌”。</blockquote></p><p> As bond yields rose, stocks became relatively less attractive, especially because the bank was signaling it would provide less support to markets and the economy. The Fed ultimately announced a reduction of its buying in December that year.</p><p><blockquote>随着债券收益率上升，股票的吸引力相对下降，特别是因为央行表示将减少对市场和经济的支持。美联储最终在当年12月宣布减少购买。</blockquote></p><p> This time, investors are already expecting the Fed to taper. The central bank has telegraphed the change in monetary policy on several occasions. Government- bond dealers expect the Fed’s monthly bond purchases, part of its effort to prop up the economy as the pandemic struck, to fall from $120 billion currently to zero by the start of 2023, according to a Goldman Sachs survey.</p><p><blockquote>这一次，投资者已经在预期美联储会缩减规模。央行已经多次发出货币政策变化的信号。高盛(Goldman Sachs)的一项调查显示，政府债券交易商预计，到2023年初，美联储每月的债券购买量将从目前的1200亿美元降至零，这是其在疫情爆发时支撑经济的努力的一部分。</blockquote></p><p> Stocks are already valued in a way that makes higher bond yields seem plausible. The S&amp;P 500’s equity-risk premium—the percentage return from earnings and dividends for the average stock on the index, minus the yield on 10-year Treasury debt, is currently at about 6 percentage points, according to Goldman Sachs. The number represents the extra return relative to safe bonds that investors demand for being in equities.</p><p><blockquote>股票的估值已经使得更高的债券收益率似乎是合理的。根据高盛的数据，标普500的股票风险溢价——该指数中平均股票的收益和股息回报率减去10年期国债收益率的百分比，目前约为6个百分点。该数字代表了投资者投资股票所需的相对于安全债券的额外回报。</blockquote></p><p> The figure is higher than the sub 6% levels often seen since 2010, implying that even if bond yields move higher, narrowing the equity-risk premium, stocks would still offer relatively strong returns in historical terms. “Market participants appear aware of tapering,” writes David Kostin, chief U.S. equity strategist at Goldman Sachs. “The equity risk premium remains high versus history.”</p><p><blockquote>这一数字高于2010年以来经常出现的低于6%的水平，这意味着即使债券收益率走高，缩小股票风险溢价，从历史角度来看，股票仍将提供相对强劲的回报。高盛首席美国股票策略师David Kostin写道：“市场参与者似乎意识到了缩减购债规模。”“与历史相比，股票风险溢价仍然很高。”</blockquote></p><p> Others agree that markets are pricing in tapering by the Fed. “An orderly and transparent removal of easy monetary policy should not be disruptive, particularly if it’s undertaken in reaction to improvements in the underlying economy, “ wrote Jason Pride, chief investment officer for private wealth at Glenmede.</p><p><blockquote>其他人同意市场正在消化美联储的缩减规模。Glenmede私人财富首席投资官贾森·普莱德(Jason Pride)写道：“有序、透明地取消宽松货币政策不应具有破坏性，特别是如果它是为了应对基础经济的改善而采取的。”</blockquote></p><p> At the very least, investors should monitor how much money the Fed pulls out from the bond market and how quickly it does so. A sharp selloff in response to the simple news that the Fed is tapering is far from certain.</p><p><blockquote>至少，投资者应该监控美联储从债券市场撤出多少资金以及撤出的速度。美联储正在缩减购债规模这一简单消息引发的大幅抛售还远未确定。</blockquote></p><p></p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Could Start ‘Tapering’ Soon. Don’t Expect It to Cause Havoc for the Stock Market This Time Around.<blockquote>美联储可能很快就会开始“缩减”。不要指望这次会对股市造成严重破坏。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Could Start ‘Tapering’ Soon. Don’t Expect It to Cause Havoc for the Stock Market This Time Around.<blockquote>美联储可能很快就会开始“缩减”。不要指望这次会对股市造成严重破坏。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barron's</strong><span class=\"h-time small\">2021-08-03 22:19</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Federal Reserve is poised to reduce the size of its bond-buying program, so stocks could head lower soon. The pain may not be acute, though, because investors generally expect the Fed to do just that.</p><p><blockquote>美联储准备缩减债券购买计划的规模，因此股市可能很快就会走低。不过，痛苦可能并不严重，因为投资者普遍预计美联储会这么做。</blockquote></p><p> It was a different scenario in May 2013, when Ben Bernanke, the Fed’s chief at the time, told Congress that if economic conditions kept improving, and policy makers were confident that would continue, the bank could pare back its buying. Bond yields leapt, and the S&amp;P 500 fell 5% in a five-day stretch in an episode known&nbsp;as the Taper Tantrum.</p><p><blockquote>2013年5月的情况有所不同，当时美联储主席本·伯南克(Ben Bernanke)告诉国会，如果经济状况持续改善，并且政策制定者有信心这种情况会持续下去，美联储可能会削减购买量。债券收益率飙升，标普500在五天内下跌5%，这一事件被称为“缩减恐慌”。</blockquote></p><p> As bond yields rose, stocks became relatively less attractive, especially because the bank was signaling it would provide less support to markets and the economy. The Fed ultimately announced a reduction of its buying in December that year.</p><p><blockquote>随着债券收益率上升，股票的吸引力相对下降，特别是因为央行表示将减少对市场和经济的支持。美联储最终在当年12月宣布减少购买。</blockquote></p><p> This time, investors are already expecting the Fed to taper. The central bank has telegraphed the change in monetary policy on several occasions. Government- bond dealers expect the Fed’s monthly bond purchases, part of its effort to prop up the economy as the pandemic struck, to fall from $120 billion currently to zero by the start of 2023, according to a Goldman Sachs survey.</p><p><blockquote>这一次，投资者已经在预期美联储会缩减规模。央行已经多次发出货币政策变化的信号。高盛(Goldman Sachs)的一项调查显示，政府债券交易商预计，到2023年初，美联储每月的债券购买量将从目前的1200亿美元降至零，这是其在疫情爆发时支撑经济的努力的一部分。</blockquote></p><p> Stocks are already valued in a way that makes higher bond yields seem plausible. The S&amp;P 500’s equity-risk premium—the percentage return from earnings and dividends for the average stock on the index, minus the yield on 10-year Treasury debt, is currently at about 6 percentage points, according to Goldman Sachs. The number represents the extra return relative to safe bonds that investors demand for being in equities.</p><p><blockquote>股票的估值已经使得更高的债券收益率似乎是合理的。根据高盛的数据，标普500的股票风险溢价——该指数中平均股票的收益和股息回报率减去10年期国债收益率的百分比，目前约为6个百分点。该数字代表了投资者投资股票所需的相对于安全债券的额外回报。</blockquote></p><p> The figure is higher than the sub 6% levels often seen since 2010, implying that even if bond yields move higher, narrowing the equity-risk premium, stocks would still offer relatively strong returns in historical terms. “Market participants appear aware of tapering,” writes David Kostin, chief U.S. equity strategist at Goldman Sachs. “The equity risk premium remains high versus history.”</p><p><blockquote>这一数字高于2010年以来经常出现的低于6%的水平，这意味着即使债券收益率走高，缩小股票风险溢价，从历史角度来看，股票仍将提供相对强劲的回报。高盛首席美国股票策略师David Kostin写道：“市场参与者似乎意识到了缩减购债规模。”“与历史相比，股票风险溢价仍然很高。”</blockquote></p><p> Others agree that markets are pricing in tapering by the Fed. “An orderly and transparent removal of easy monetary policy should not be disruptive, particularly if it’s undertaken in reaction to improvements in the underlying economy, “ wrote Jason Pride, chief investment officer for private wealth at Glenmede.</p><p><blockquote>其他人同意市场正在消化美联储的缩减规模。Glenmede私人财富首席投资官贾森·普莱德(Jason Pride)写道：“有序、透明地取消宽松货币政策不应具有破坏性，特别是如果它是为了应对基础经济的改善而采取的。”</blockquote></p><p> At the very least, investors should monitor how much money the Fed pulls out from the bond market and how quickly it does so. A sharp selloff in response to the simple news that the Fed is tapering is far from certain.</p><p><blockquote>至少，投资者应该监控美联储从债券市场撤出多少资金以及撤出的速度。美联储正在缩减购债规模这一简单消息引发的大幅抛售还远未确定。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/federal-reserve-stocks-tapering-51627939038?mod=hp_LEAD_2_B_1\">Barron's</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/federal-reserve-stocks-tapering-51627939038?mod=hp_LEAD_2_B_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145562808","content_text":"The Federal Reserve is poised to reduce the size of its bond-buying program, so stocks could head lower soon. The pain may not be acute, though, because investors generally expect the Fed to do just that.\nIt was a different scenario in May 2013, when Ben Bernanke, the Fed’s chief at the time, told Congress that if economic conditions kept improving, and policy makers were confident that would continue, the bank could pare back its buying. Bond yields leapt, and the S&P 500 fell 5% in a five-day stretch in an episode known as the Taper Tantrum.\nAs bond yields rose, stocks became relatively less attractive, especially because the bank was signaling it would provide less support to markets and the economy. The Fed ultimately announced a reduction of its buying in December that year.\nThis time, investors are already expecting the Fed to taper. The central bank has telegraphed the change in monetary policy on several occasions. Government- bond dealers expect the Fed’s monthly bond purchases, part of its effort to prop up the economy as the pandemic struck, to fall from $120 billion currently to zero by the start of 2023, according to a Goldman Sachs survey.\nStocks are already valued in a way that makes higher bond yields seem plausible. The S&P 500’s equity-risk premium—the percentage return from earnings and dividends for the average stock on the index, minus the yield on 10-year Treasury debt, is currently at about 6 percentage points, according to Goldman Sachs. The number represents the extra return relative to safe bonds that investors demand for being in equities.\nThe figure is higher than the sub 6% levels often seen since 2010, implying that even if bond yields move higher, narrowing the equity-risk premium, stocks would still offer relatively strong returns in historical terms. “Market participants appear aware of tapering,” writes David Kostin, chief U.S. equity strategist at Goldman Sachs. “The equity risk premium remains high versus history.”\nOthers agree that markets are pricing in tapering by the Fed. “An orderly and transparent removal of easy monetary policy should not be disruptive, particularly if it’s undertaken in reaction to improvements in the underlying economy, “ wrote Jason Pride, chief investment officer for private wealth at Glenmede.\nAt the very least, investors should monitor how much money the Fed pulls out from the bond market and how quickly it does so. A sharp selloff in response to the simple news that the Fed is tapering is far from certain.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179359184,"gmtCreate":1626487987948,"gmtModify":1633926318400,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/179359184","repostId":"1198202103","repostType":4,"isVote":1,"tweetType":1,"viewCount":250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898009724,"gmtCreate":1628437856768,"gmtModify":1633747142951,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/898009724","repostId":"2157490509","repostType":4,"isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806994165,"gmtCreate":1627622412957,"gmtModify":1633757665523,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment.&nbsp; Thanks&nbsp;","listText":"Please like and comment.&nbsp; Thanks&nbsp;","text":"Please like and comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/806994165","repostId":"2155135477","repostType":4,"isVote":1,"tweetType":1,"viewCount":490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178209094,"gmtCreate":1626821845318,"gmtModify":1633770800953,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/178209094","repostId":"2152657163","repostType":4,"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173963548,"gmtCreate":1626601241284,"gmtModify":1633925552718,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and share","listText":"Please like and share","text":"Please like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/173963548","repostId":"1183956332","repostType":4,"isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179340435,"gmtCreate":1626488537627,"gmtModify":1633926310284,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179340435","repostId":"1169536573","repostType":4,"repost":{"id":"1169536573","kind":"news","pubTimestamp":1626448731,"share":"https://www.laohu8.com/m/news/1169536573?lang=zh_CN&edition=full","pubTime":"2021-07-16 23:18","market":"us","language":"en","title":"Coupa Shares Extend Losses After Post-Analyst Day Selloff<blockquote>分析师日抛售后，Coupa股价扩大跌幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169536573","media":"Thestreet","summary":"Coupa Software traded lower for a second day Friday, extending Thursday's near 10% loss, as analysts reassessed their outlooks for the financial management software company following a disappointing analyst day event.Coupa hosted a virtual analyst day on Thursday, when the platform provider shared additional detail about its Coupa Pay service, and also provided an update on its longer-term prospects.Analysts honed in on the more conservative outlook provided by Coupa's management team as the lik","content":"<p>Coupa Software(<b>COUP</b>)&nbsp;traded lower for a second day Friday, extending Thursday's near 10% loss, as analysts reassessed their outlooks for the financial management software company following a disappointing analyst day event.</p><p><blockquote>Coupa软件（<b>COUP</b>）周五连续第二天走低，延续了周四近10%的跌幅，分析师在经历了令人失望的分析师日活动后重新评估了对这家财务管理软件公司的前景。</blockquote></p><p> Coupa hosted a virtual analyst day on Thursday, when the platform provider shared additional detail about its Coupa Pay service, and also provided an update on its longer-term prospects.</p><p><blockquote>Coupa周四举办了虚拟分析师日，该平台提供商分享了有关其Coupa Pay服务的更多细节，并提供了有关其长期前景的最新信息。</blockquote></p><p> Analysts honed in on the more conservative outlook provided by Coupa's management team as the likely reason behind Thursday's selloff, though were generally sanguine about the company's longer-term prospects, with Piper Sandler one of the the few Wall Street investment firms to lower its one-year price target.</p><p><blockquote>分析师们认为Coupa管理团队提供的更为保守的前景可能是周四抛售背后的原因，但他们普遍对该公司的长期前景持乐观态度，Piper Sandler是少数几家下调一年股价的华尔街投资公司之一。价格目标。</blockquote></p><p> Piper Sandler analysts also focused on lack of progress with Coupa Pay, noting that “… considering the necessary conservatism that is needed to continue the well-known beat and raise cadence, the set-up was always less than ideal.” They held their overweight rating on the stock though lowered their price target to $295 from $300.</p><p><blockquote>Piper Sandler分析师还关注了Coupa Pay缺乏进展的问题，并指出“……考虑到继续众所周知的节拍和提高节奏所需的必要保守主义，这种设置总是不太理想。”他们维持对该股的跑赢大盘评级，但将目标价从300美元下调至295美元。</blockquote></p><p> Truist Securities was slightly more upbeat, though admitted investors “could have been disappointed by either what they heard from an attach rate perspective on Coupa Pay or potentially were disappointed that it’s likely a multi-year time line before Coupa Pay really moves the needle.” They held their buy rating and price target of $326.</p><p><blockquote>Truist Securities稍微乐观一些，尽管承认投资者“可能会对他们从Coupa Pay的附加利率角度听到的消息感到失望，或者可能会对Coupa Pay真正发挥作用可能需要多年时间线感到失望。”他们维持买入评级和326美元的目标价。</blockquote></p><p> Barclays analysts noted that while Coupa couldn’t meet “the very high expectations from the Street” for its Coupa Pay service it is maintaining its positive outlook. The investment bank held its equal weight rating on the shares and one-year price target of $250.</p><p><blockquote>巴克莱分析师指出，虽然Coupa无法满足“华尔街对其Coupa Pay服务的极高期望”，但它仍保持积极的前景。该投资银行维持该股等权重评级，一年目标价为250美元。</blockquote></p><p> Coupa shares plunged last monthafter the companyprovided a tepid forecastthat raised questions about its pace of billings growth.&nbsp;A number of analysts cut their price targets on the San Mateo, Calif., based company at the time, even after it reported a surprise profit and better-than-expected revenue forecasts.</p><p><blockquote>上个月，Coupa股价暴跌，此前该公司提供了一份不温不火的预测，引发了人们对其账单增长速度的质疑。当时，许多分析师下调了这家总部位于加州圣马特奥的公司的目标价，尽管该公司公布了意外的利润和好于预期的收入预测。</blockquote></p><p> At last check, Coupa shares were down 2.24% at $221.04. The stock has fallen 32.7% year to date.</p><p><blockquote>据上次检查，Coupa股价下跌2.24%，至221.04美元。该股今年迄今已下跌32.7%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coupa Shares Extend Losses After Post-Analyst Day Selloff<blockquote>分析师日抛售后，Coupa股价扩大跌幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoupa Shares Extend Losses After Post-Analyst Day Selloff<blockquote>分析师日抛售后，Coupa股价扩大跌幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Thestreet</strong><span class=\"h-time small\">2021-07-16 23:18</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Coupa Software(<b>COUP</b>)&nbsp;traded lower for a second day Friday, extending Thursday's near 10% loss, as analysts reassessed their outlooks for the financial management software company following a disappointing analyst day event.</p><p><blockquote>Coupa软件（<b>COUP</b>）周五连续第二天走低，延续了周四近10%的跌幅，分析师在经历了令人失望的分析师日活动后重新评估了对这家财务管理软件公司的前景。</blockquote></p><p> Coupa hosted a virtual analyst day on Thursday, when the platform provider shared additional detail about its Coupa Pay service, and also provided an update on its longer-term prospects.</p><p><blockquote>Coupa周四举办了虚拟分析师日，该平台提供商分享了有关其Coupa Pay服务的更多细节，并提供了有关其长期前景的最新信息。</blockquote></p><p> Analysts honed in on the more conservative outlook provided by Coupa's management team as the likely reason behind Thursday's selloff, though were generally sanguine about the company's longer-term prospects, with Piper Sandler one of the the few Wall Street investment firms to lower its one-year price target.</p><p><blockquote>分析师们认为Coupa管理团队提供的更为保守的前景可能是周四抛售背后的原因，但他们普遍对该公司的长期前景持乐观态度，Piper Sandler是少数几家下调一年股价的华尔街投资公司之一。价格目标。</blockquote></p><p> Piper Sandler analysts also focused on lack of progress with Coupa Pay, noting that “… considering the necessary conservatism that is needed to continue the well-known beat and raise cadence, the set-up was always less than ideal.” They held their overweight rating on the stock though lowered their price target to $295 from $300.</p><p><blockquote>Piper Sandler分析师还关注了Coupa Pay缺乏进展的问题，并指出“……考虑到继续众所周知的节拍和提高节奏所需的必要保守主义，这种设置总是不太理想。”他们维持对该股的跑赢大盘评级，但将目标价从300美元下调至295美元。</blockquote></p><p> Truist Securities was slightly more upbeat, though admitted investors “could have been disappointed by either what they heard from an attach rate perspective on Coupa Pay or potentially were disappointed that it’s likely a multi-year time line before Coupa Pay really moves the needle.” They held their buy rating and price target of $326.</p><p><blockquote>Truist Securities稍微乐观一些，尽管承认投资者“可能会对他们从Coupa Pay的附加利率角度听到的消息感到失望，或者可能会对Coupa Pay真正发挥作用可能需要多年时间线感到失望。”他们维持买入评级和326美元的目标价。</blockquote></p><p> Barclays analysts noted that while Coupa couldn’t meet “the very high expectations from the Street” for its Coupa Pay service it is maintaining its positive outlook. The investment bank held its equal weight rating on the shares and one-year price target of $250.</p><p><blockquote>巴克莱分析师指出，虽然Coupa无法满足“华尔街对其Coupa Pay服务的极高期望”，但它仍保持积极的前景。该投资银行维持该股等权重评级，一年目标价为250美元。</blockquote></p><p> Coupa shares plunged last monthafter the companyprovided a tepid forecastthat raised questions about its pace of billings growth.&nbsp;A number of analysts cut their price targets on the San Mateo, Calif., based company at the time, even after it reported a surprise profit and better-than-expected revenue forecasts.</p><p><blockquote>上个月，Coupa股价暴跌，此前该公司提供了一份不温不火的预测，引发了人们对其账单增长速度的质疑。当时，许多分析师下调了这家总部位于加州圣马特奥的公司的目标价，尽管该公司公布了意外的利润和好于预期的收入预测。</blockquote></p><p> At last check, Coupa shares were down 2.24% at $221.04. The stock has fallen 32.7% year to date.</p><p><blockquote>据上次检查，Coupa股价下跌2.24%，至221.04美元。该股今年迄今已下跌32.7%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/coupa-software-coup-rebound-selloff-analysts\">Thestreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COUP":"Coupa Software Inc"},"source_url":"https://www.thestreet.com/investing/coupa-software-coup-rebound-selloff-analysts","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169536573","content_text":"Coupa Software(COUP) traded lower for a second day Friday, extending Thursday's near 10% loss, as analysts reassessed their outlooks for the financial management software company following a disappointing analyst day event.\nCoupa hosted a virtual analyst day on Thursday, when the platform provider shared additional detail about its Coupa Pay service, and also provided an update on its longer-term prospects.\nAnalysts honed in on the more conservative outlook provided by Coupa's management team as the likely reason behind Thursday's selloff, though were generally sanguine about the company's longer-term prospects, with Piper Sandler one of the the few Wall Street investment firms to lower its one-year price target.\nPiper Sandler analysts also focused on lack of progress with Coupa Pay, noting that “… considering the necessary conservatism that is needed to continue the well-known beat and raise cadence, the set-up was always less than ideal.” They held their overweight rating on the stock though lowered their price target to $295 from $300.\nTruist Securities was slightly more upbeat, though admitted investors “could have been disappointed by either what they heard from an attach rate perspective on Coupa Pay or potentially were disappointed that it’s likely a multi-year time line before Coupa Pay really moves the needle.” They held their buy rating and price target of $326.\nBarclays analysts noted that while Coupa couldn’t meet “the very high expectations from the Street” for its Coupa Pay service it is maintaining its positive outlook. The investment bank held its equal weight rating on the shares and one-year price target of $250.\nCoupa shares plunged last monthafter the companyprovided a tepid forecastthat raised questions about its pace of billings growth. A number of analysts cut their price targets on the San Mateo, Calif., based company at the time, even after it reported a surprise profit and better-than-expected revenue forecasts.\nAt last check, Coupa shares were down 2.24% at $221.04. The stock has fallen 32.7% year to date.","news_type":1,"symbols_score_info":{"COUP":0.9}},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149136707,"gmtCreate":1625708491909,"gmtModify":1633938143965,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/149136707","repostId":"2149531974","repostType":4,"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":867967341,"gmtCreate":1633188921928,"gmtModify":1633188922325,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Comment and like please. Thanks&nbsp;","listText":"Comment and like please. Thanks&nbsp;","text":"Comment and like please. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/867967341","repostId":"2172618769","repostType":4,"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":885493195,"gmtCreate":1631807945217,"gmtModify":1631888200784,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/885493195","repostId":"1169233466","repostType":4,"repost":{"id":"1169233466","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631804939,"share":"https://www.laohu8.com/m/news/1169233466?lang=zh_CN&edition=full","pubTime":"2021-09-16 23:08","market":"us","language":"en","title":"Beyond Meat stock dropped nearly 5% in morning trading<blockquote>Beyond Meat股价早盘下跌近5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169233466","media":"Tiger Newspress","summary":"Beyond Meat stock dropped nearly 5% in morning trading after Piper Sandler downgraded the company to","content":"<p>Beyond Meat stock dropped nearly 5% in morning trading&nbsp;after Piper Sandler&nbsp;downgraded&nbsp;the company to an underweight rating.</p><p><blockquote>在Piper Sandler将Beyond Meat评级下调至跑输大盘评级后，该公司股价在早盘交易中下跌近5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/58f2b15e1f14a11787379dd95a4d8eb6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Shares of Beyond Meat Inc. took a hit Thursday, after Piper Sandler analyst Michael Lavery turned bearish on the plant-based meat company, citing a weaker growth outlook and concern the outlook for foodservice sales may be overly optimistic.</p><p><blockquote>Piper Sandler分析师Michael Lavery对这家植物性肉类公司持悲观态度，理由是增长前景疲软，并担心餐饮服务销售前景可能过于乐观，周四，该公司股价遭受重创。</blockquote></p><p> Lavery downgraded the stock to underweight, after being at neutral for the past eight months. He cut his price target to $95, which is 14% below Wednesday's closing price, from $120.</p><p><blockquote>在过去八个月保持中性后，拉威利将该股评级下调至跑输大盘。他将目标价从120美元下调至95美元，较周三收盘价低14%。</blockquote></p><p> \"Beyond is an early leader in plant-based meat, but we believe its current all-channel retail momentum lags consensus expectations, and our foodservice estimates may be high, too,\" Lavery wrote in a note to clients.</p><p><blockquote>Lavery在给客户的一份报告中写道：“Beyond是植物性肉类领域的早期领导者，但我们认为其目前的全渠道零售势头落后于普遍预期，我们的餐饮服务预期可能也很高。”</blockquote></p><p> He estimates that the company's U.S. retail sales fell by about 10% in the third quarter, with multi-outlet with convenience store channel sales down 8% and natural channel sales down 27%.</p><p><blockquote>他估计，该公司第三季度美国零售额下降约10%，其中多网点与便利店渠道销售额下降8%，自然渠道销售额下降27%。</blockquote></p><p> \"Beyond's retail sales declines are worse than all of its food peers in our coverage besides B&amp;G Foods,\" Lavery wrote. He rates B&amp;G&nbsp;at neutral.</p><p><blockquote>Lavery写道：“在我们的报道中，Beyond的零售额下降幅度比除B&amp;G Foods之外的所有食品同行都要严重。”他对B&amp;G的评级为中性。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Meat stock dropped nearly 5% in morning trading<blockquote>Beyond Meat股价早盘下跌近5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Meat stock dropped nearly 5% in morning trading<blockquote>Beyond Meat股价早盘下跌近5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-16 23:08</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Beyond Meat stock dropped nearly 5% in morning trading&nbsp;after Piper Sandler&nbsp;downgraded&nbsp;the company to an underweight rating.</p><p><blockquote>在Piper Sandler将Beyond Meat评级下调至跑输大盘评级后，该公司股价在早盘交易中下跌近5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/58f2b15e1f14a11787379dd95a4d8eb6\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Shares of Beyond Meat Inc. took a hit Thursday, after Piper Sandler analyst Michael Lavery turned bearish on the plant-based meat company, citing a weaker growth outlook and concern the outlook for foodservice sales may be overly optimistic.</p><p><blockquote>Piper Sandler分析师Michael Lavery对这家植物性肉类公司持悲观态度，理由是增长前景疲软，并担心餐饮服务销售前景可能过于乐观，周四，该公司股价遭受重创。</blockquote></p><p> Lavery downgraded the stock to underweight, after being at neutral for the past eight months. He cut his price target to $95, which is 14% below Wednesday's closing price, from $120.</p><p><blockquote>在过去八个月保持中性后，拉威利将该股评级下调至跑输大盘。他将目标价从120美元下调至95美元，较周三收盘价低14%。</blockquote></p><p> \"Beyond is an early leader in plant-based meat, but we believe its current all-channel retail momentum lags consensus expectations, and our foodservice estimates may be high, too,\" Lavery wrote in a note to clients.</p><p><blockquote>Lavery在给客户的一份报告中写道：“Beyond是植物性肉类领域的早期领导者，但我们认为其目前的全渠道零售势头落后于普遍预期，我们的餐饮服务预期可能也很高。”</blockquote></p><p> He estimates that the company's U.S. retail sales fell by about 10% in the third quarter, with multi-outlet with convenience store channel sales down 8% and natural channel sales down 27%.</p><p><blockquote>他估计，该公司第三季度美国零售额下降约10%，其中多网点与便利店渠道销售额下降8%，自然渠道销售额下降27%。</blockquote></p><p> \"Beyond's retail sales declines are worse than all of its food peers in our coverage besides B&amp;G Foods,\" Lavery wrote. He rates B&amp;G&nbsp;at neutral.</p><p><blockquote>Lavery写道：“在我们的报道中，Beyond的零售额下降幅度比除B&amp;G Foods之外的所有食品同行都要严重。”他对B&amp;G的评级为中性。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BYND":"Beyond Meat, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169233466","content_text":"Beyond Meat stock dropped nearly 5% in morning trading after Piper Sandler downgraded the company to an underweight rating.\n\nShares of Beyond Meat Inc. took a hit Thursday, after Piper Sandler analyst Michael Lavery turned bearish on the plant-based meat company, citing a weaker growth outlook and concern the outlook for foodservice sales may be overly optimistic.\nLavery downgraded the stock to underweight, after being at neutral for the past eight months. He cut his price target to $95, which is 14% below Wednesday's closing price, from $120.\n\"Beyond is an early leader in plant-based meat, but we believe its current all-channel retail momentum lags consensus expectations, and our foodservice estimates may be high, too,\" Lavery wrote in a note to clients.\nHe estimates that the company's U.S. retail sales fell by about 10% in the third quarter, with multi-outlet with convenience store channel sales down 8% and natural channel sales down 27%.\n\"Beyond's retail sales declines are worse than all of its food peers in our coverage besides B&G Foods,\" Lavery wrote. He rates B&G at neutral.","news_type":1,"symbols_score_info":{"BYND":0.9}},"isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882786119,"gmtCreate":1631721056231,"gmtModify":1631890053102,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment thanks&nbsp;","listText":"Please like and comment thanks&nbsp;","text":"Please like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/882786119","repostId":"2167859607","repostType":4,"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831203859,"gmtCreate":1629328033971,"gmtModify":1633685735794,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/831203859","repostId":"2160737181","repostType":4,"isVote":1,"tweetType":1,"viewCount":576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890138817,"gmtCreate":1628086278539,"gmtModify":1633753728696,"author":{"id":"3579743164156658","authorId":"3579743164156658","name":"sheenayam","avatar":"https://static.tigerbbs.com/fe1b57a8371314fd64ce0840001df6b2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579743164156658","authorIdStr":"3579743164156658"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/890138817","repostId":"2156060681","repostType":4,"isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}